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ABSTRACT OF DISSERTATION

MICROELECTRODE ARRAY RECORDINGS OF L-GLUTAMATE DYNAMICS
IN THE BRAINS OF FREELY MOVING RATS
L-glutamate (Glu) is the predominant excitatory neurotransmitter in
the mammalian central nervous system (CNS) and is associated with a wide
variety of functions including motor behavior and sensory perception.

While

microdialysis methods have been used to record tonic levels of Glu, little is
known about the more rapid changes in Glu signals that may occur in awake
animals.

We have previously reported acute recording methods using an

enzyme-based microelectrode array (MEA) with fast temporal resolution (800
msec), that is minimally invasive and is capable of detecting low levels of Glu (<
0.2 µM) in anesthetized animals with little interference from other analytes.

We

have made a series of modifications to the MEA design to allow for reliable
measures in the brain of awake behaving rats.

In these studies, we

characterized the effects of chronic implantation of the MEA into the striatum and
prefrontal cortex (PFC) of Fischer 344 and Long Evans rats.

We measured

resting levels of Glu and local application of Glu for 7 days without a significant
loss of sensitivity and determined that Glu measures due to exogenous Glu
varied between rat strain and brain region.

In addition, we determined the

viability of the recordings in the brains of awake animals. We performed studies
of tail-pinch induced stress which caused an increase in Glu in the striatum and
PFC of Long Evans and Fischer 344 rats. Histological data show that chronic
implantation of our MEAs caused minimal injury to the CNS. Taken together, our

data support that chronic recordings of tonic and phasic Glu can be carried out in
awake rats reliably for 7 days in vivo allowing for longer term studies of Glu
regulation in behaving rats.
Keywords: L-Glutamate; Prefrontal Cortex; Striatum; Unanesthetized; Freely
Behaving
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Chapter One: Introduction
Techniques for Studying L-Glutamate: Microelectrode Arrays vs. Microdialysis
Historically, Glu neurotransmission has been studied in brain tissue using
microdialysis and electrophysiological methods such as patch-clamp recordings
(Bagley and Moghaddam, 1997; Fitzpatrick et al., 2001; Kennedy et al., 2002;
Shou et al., 2004; Tucci et al., 1997). Currently, the most common technique
employed to study Glu levels in the intact mammalian brain is in vivo
microdialysis. Many microdialysis studies of Glu levels have been performed in
anesthetized and awake animal models (Bagley and Moghaddam, 1997;
Kennedy et al., 2002; Shou et al., 2004; Tucci et al., 1997). Microdialysis allows
for the simultaneous measurements of multiple analytes at low detection levels.
However, the fast dynamics of Glu regulation may be muted when using
microdialysis due to the limits in temporal resolution of this method. Progress on
increasing the temporal resolution by coupling microdialysis with capillary
electrophoresis (Tucci et al. 1997; Kennedy et al., 2002) has decreased sampling
rates to every 12-18 seconds which is still far above the subsecond rates
required. In addition, several microdialysis studies have reported that the Glu
overflow measured with this technique is not tetrodotoxin (TTX) -dependent,
supporting the idea that the Glu signals measured using microdialysis are not
neuronally derived (Timmermann and Westerink, 1997; Baker et al., 2002;
Melendez et al., 2005). Furthermore, it has been shown that there is extensive
damage to the brain tissue up to 1.4 mm away from the microdialysis probe
implant site (Clapp-Lilly et al., 1999; Borland et al., 2005) which may affect
neurotransmitter signaling, release, and uptake.

Despite the incorporation of

capillary electrophoresis, it is doubtful that microdialysis can achieve the
temporal resolution required to see the subsecond dynamics of Glu, mainly due
to the physical limitations associated with the diffusional process required to
cross the dialysis membrane. Since neurochemical levels and behaviors are
capable of changing rapidly (sub-second), it is important to develop a technique
that has an adequate temporal resolution.
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Our laboratory has recently developed an enzyme-based microelectrode
array (MEA) that is capable of selectively detecting low levels (0.2 µM) of Glu
with sub-second (500 - 800 msec) time resolution that is virtually free from CNS
interferents, such as 3,4-dihydroxy-phenylacetic acid (DOPAC) and ascorbate
(Burmeister et al., 2000, 2003). The present studies address the adaptation and
validation of MEA recordings in the awake, freely moving rat, as well as address
clinically relevant issues, such as measures of Glu resting levels, the effects of
chronic implantation of the MEAs on surrounding brain tissue, Glu clearance,
variance in phasic and tonic Glu between brain regions, and the effects of stress
on Glu levels. First, we adapted our methodology for chronic recordings of tonic
(resting) levels and phasic (rapid) changes of Glu in awake rats. Second, we
investigated the reproducibility of such methods for chronic measures in the rat
PFC and striatum over several days. Third, studies with pharmacological agents
were carried out to better understand the specificity of these measures for Glu
and the in vivo source(s) of these signals. Fourth, extracellular levels of Glu were
investigated during a behavior related situation (stress induced by a tail-pinch) in
the brain of awake rats.

Finally, we carried out histopathological studies to

determine the damage produced by the MEA’s to surrounding brain tissue.
L-Glutamate in the Mammalian Central Nervous System
There are four main classification criteria for a neurotransmitter: 1)
presynaptic localization, 2) release by a physiological stimuli, 3) identical action
with naturally occurring transmitter, and 4) mechanism for rapid termination of
transmitter action. In the mid – 1980s, Glu met these criteria and was accepted
as a candidate for a neurotransmitter (Krnjevic, 1986; Watkins, 1986). Today we
know that Glu is the predominant excitatory neurotransmitter in the mammalian
CNS. Glu has been shown to link many structures within the brain, including the
cerebral cortex, hippocampus, basolateral amygdala, substantia nigra, nucleus
accumbens, striatum, superior colliculus, caudate nucleus, red nucleus, and the
pons. Studies that examine the exact localization of Glu have been hard to
accomplish successfully, mainly due to the abundance of Glu in the CNS and its
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metabolic functions and the role of Glu as a precursor for γ-aminobutyric acid
(GABA), the major inhibitory neurotransmitter in the brain. Glu has been shown
to play a role in development, plasticity, learning and memory, cognition, sensory
systems, and motor systems through its interactions in the CNS. In addition, Glu
has also been associated with many brain disorders, including schizophrenia,
addiction, stroke, traumatic brain injury, Huntington’s Disease, amyotophic lateral
sclerosis, Parkinson’s Disease and epilepsy.
For the scope of these studies, the brain areas of interest were the
striatum and the PFC. In the rodent, the medial PFC (infralimbic and prelimbic
areas) is suggested to be the brain area responsible for executing function,
including working memory (Aultman and Moghaddam, 2001; Delatour and
Gisquet-Verrier, 1996; Floresco et al., 1996; Granon and Poucet, 1995; Kesner
et al., 1996; and Seamans et al., 1995) and other cognitive functions. All PFC
efferents and the majority of the afferents to the PFC, such as projections from
the thalamus, hippocampus, and amygdala, are glutamatergic.

Glu is also

abundant in the striatum, which is important to these studies because the PFC
and striatum send and receive input from each other and are interconnected via
the limbic system and motor controls, which are implicated in various behavioral
functions including the stress response.
L-Glutamate Synthesis, Receptors, and Transporters
Glu in the brain is derived almost entirely through local synthesis. This
may occur through multiple pathways.

In the brain, Glu is formed primarily

through the Krebs cycle, by the transamination of α-ketoglutarate by Glu
dehydrogenase, and also from glutamine derived from glial cells that can be
converted in the nerve terminal to Glu via glutaminase. A brief overview of the
pathways mentioned here can be seen in Figure 1.1. Glu in the nerve terminal is
then transferred, via a highly specific Cl- -dependent vesicular Glu transporter
(vGluT), and stored in synaptic vesicles until it is released into the synaptic cleft.
In glutamatergic neurons, Glu is released through a calcium-dependent
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exocytotic process where the synaptic vesicle fuses with the presynaptic
neuronal cell membrane when the nerve terminal is depolarized.
Once Glu is released into the synaptic cleft, the signal is terminated mainly
by uptake into glial cells through high affinity sodium-dependent plasma
membrane Glu transporters; the Glu aspartate transporter (GLAST-1) and Glu
transporter-1 (GLT-1) (Danbolt, 2001; Fillenz, 1995). Glu is then converted to
glutamine and can be transported back to the presynaptic glutamatergic nerve
terminal, where it can again be converted into Glu and stored in synaptic vesicles
and used for release. Glu near the synaptic cleft may also be terminated through
uptake on the postsynaptic nerve terminal by a sodium-dependent plasma
membrane excitatory amino acid carrier (EAAC).

Additionally, in the human

brain, there are two more transporters, EAAT4 (cerebellum) and EAAT 5 (retina).
As the primary area of interest for this document lies in the striatum and PFC of
rats, EAAT4 and EAAT 5 will not be discussed. A review of the primary location
of Glu transporters in the rat brain can be found in Table 1.1.
There are two types of Glu receptors, ionotropic (iGluR) and metabotropic
(mGluR).

The iGluRs consist of α-amino-3-hydroxy-5-methyl-4-isoxazole

propionate (AMPA), kainate, and N-methyl-D-aspartate (NMDA) receptors,
named after select agonists.

The AMPA receptor is involved in the fast

neurotransmission of excitation and utilizes sodium and Glu as endogenous
agonists.

The NMDA receptor is involved in slow, prolonged neuronal

depolarization. This receptor is unique in that it requires two ligands, Glu and
glycine, for receptor activation. Additionally, the NMDA receptor is both ligandgated, using sodium, calcium, and Glu as endogenous agonists, and voltagegated due to the magnesium channel block. A brief review of iGluRs can be
found in Table 1.2.
mGluRs are divided into three groups (I, II, and III).

mGluRs contain

seven transmembrane spanning domains with their ligand-binding sites located
on the extracellular N-terminus and are coupled to G-proteins. mGluRs require
subsequent second messenger signaling to elicit a response and are therefore
generally slower acting than iGluRs. The mGluR Group I (mGluR 1 and 5) are
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linked to phospholipase C (PLC) and are generally excitatory. While mGluR
Group II (mGluR 2 and 3) and III (mGluR 4, 6, 7, and 8) act by inhibiting adenyl
cyclase, and therefore cAMP formation, making mGluR Group II and III generally
inhibitory.

mGluRs are thought to modulate brain excitability through their

presynaptic, postsynaptic, and glial activity (Table 1.3). As is evident from this
brief discussion, the glutamatergic synapse is highly involved with its iGluRs,
mGluRs, and transporters. As such, Figure 1.2 outlines a typical glutamatergic
synapse.
The Role of Anesthesia on the Glutamatergic System in the Central Nervous
System
The effects of anesthesia on the glutamatergic system in the CNS have
only recently begun to be studied. Various anesthetics may have widely differing
effects on the glutamatergic system, based on their target of action.

One

anesthetic of interest, isoflurane, a halogenated ether commonly used in the
operating room, was first used clinically in 1981 affects Glu neurotransmission.
Liachenko et al. (1999) reported inhibition by isoflurane on both the release and
re-uptake of Glu with an EC50 in the clinical dose range. Additionally, patchclamp recordings have shown a decrease in glutamatergic neuronal excitability
with isoflurane. However, these affects have been shown to return to normal
within 30 minutes after the cessation of administration, making it a good
candidate for use with humans as well as for recovery surgery with rodents.
Another anesthetic commonly used when studying rodents is urethane
due to its ability to produce a high plane of anesthesia for approximately eight
hours without the need for re-administration. While urethane is thought to have
minimal effects on the dopaminergic system (Sabeti et al., 2003), little is known
about its effects on the glutamatergic system. Bindman et al. (1988) reported
that there was no difference observed between in vitro brain slices and urethaneanesthetized rats in resting membrane potential, action potential amplitude or
membrane capacitance. However, a diminished neuronal activity associated with
urethane was observed in several studies (Albrecht and Davidowa, 1989; Dyer
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and Rigdon, 1987; Girman et al., 1999). Resting Glu levels in the anesthetized
rat striatum were reported to be approximately 1.3 – 2.7 µM (Cellar, et al., 2005),
whereas, in an awake rat model resting Glu levels in the striatum were reported
to be 0.20-0.82 µM (Di Cara et al., 2001; Segovia et al., 2001). Additionally,
microdialysis measures of resting Glu in the frontal cortex of the awake rat
ranged between ~2 µM and ~9 µM (Baotell et al., 1995; Rocha et al., 1996).
These discrepancies observed in resting Glu levels using microdialysis may be
explained by differences in the sampling time employed, or the origin of the Glu
pool being sampled, the brain region, as well as the effects of anesthesia. It is
entirely possible that there may be differences observed in tonic (resting levels)
and phasic Glu levels in the brain as a result of the use or type of anesthetic.
L-Glutamate in the Awake Animal Model
Several methods have been employed to measure Glu in the awake rat
model, including microdialysis. However, none have the combined advantages
of sub-second recording times, low levels of detection for Glu, and minimally
invasiveness. Recordings of Glu in freely moving animals have several distinct
advantages. First, this approach allows for monitoring Glu neurotransmission
without the effects of anesthesia.

Anesthetics are known to alter resting levels

and phasic Glu release dynamics (Liachenko et al., 1998, 1999). Second, our
microelectrodes can reliably record Glu for at least one week in the brain of the
freely moving rat. This means that subsequent measures can be made over
multiple days rather than only one day as in anesthetized amperometric
recordings as well as anesthetized and awake microdialysis studies. Third, freely
moving animal recordings can be coupled to behavioral studies to investigate
changes in Glu that are due to behavior. This allows us to directly couple a
behavioral event with a physiological response.
Of particular interest to us is the involvement of stress in neurological
disorders, such as addiction, schizophrenia, and Parkinson’s disease. Stress
can play a major role in the development, progression and exacerbation of
symptoms associated with these disorders (Carlsson and Carlsson, 1990; Grace,
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1991; Greenamyre, 1993; Del Arco et al., 1998, 1999). It has been suggested
that Glu neurotransmission activation in the PFC is a common mechanism that
may allow stress to influence both normal and abnormal processes that maintain
cognition and affect (Moghaddam, 2002). Glutamatergic neurotransmission in
the PFC modulates or mediates many aspects of the stress response, such as
activation of the hypothalamic-pituitary-adrenal (HPA) axis and monoamine
neurotransmission. Previous studies (Bagley and Moghaddam, 1997; Bland et
al. 1999; Jedema and Moghaddam, 1994; Takahata and Moghaddam, 1998)
have reported on stress response and Glu involvement in unanaesthetized
animals, however, these studies did not have the temporal and spatial resolution
that is possible with our ceramic MEAs and therefore, may not have detected the
fast dynamics of Glu as a neurotransmitter. In many psychiatric disorders, such
as addiction, depression, and schizophrenia, stress appears to be a major
influence in the course and outcome of the disease. A better understanding in
these areas may lead to more effective treatments.
Thesis Outline
As is evident from this discussion of the possible effects of anesthesia on
the glutamatergic system and the techniques available for studying Glu in the
awake animal, there is a great need to examine the glutamatergic system in a
model that is free from anesthetics and has the capabilities to record low levels of
Glu with high temporal resolution over long durations.

The work presented

herein serves not only to develop and characterize a new technique designed to
record Glu in the freely moving animal, but also to serve as a means to expand
on the current knowledge of resting levels and behavior-evoked Glu in the awake
rat. In Chapter Three, we investigated resting Glu levels in the striatum and PFC
of two rat strains, the Fischer 344 rat commonly used in age-related studies, and
the Long Evans rat commonly used in behavioral based studies.

We

accomplished this by using an enzyme-based ceramic microelectrode array
configured to selectively measure Glu utilizing a self-referencing technique. We
determined resting Glu levels on days 3, 5, and 7 post-implantation prior to
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stimulation. We also examined potential mechanisms of action for regulating
resting levels of Glu as well as the effect of urethane anesthetic on resting Glu
levels. Our results show that tonic Glu levels were significantly higher in the PFC
of Long Evans rats compared to the PFC of Fischer 344 rats and the striatum of
Long Evans rats and urethane significantly decreased tonic Glu levels (58%) in
the PFC of Long Evans rats. In addition, we showed that independent local
application of TTX and mGluR2/3 agonist (LY379268) decreased resting Glu
levels while the mGluR2/3 antagonist (LY341495) increased those levels. Taken
together, these results show that the pool of Glu being sampled was partially
neuronally derived and was regulated presynaptically through mGluRs.

In

addition, data showed that tonic Glu levels were significantly different between
rat strains as well as brain regions and resting Glu levels decreased with
urethane administration.
Chapter Four further examines the glutamatergic system in the awake rat
through local application of exogenous Glu and the differences observed in
relation to time, brain region, and rat strain. We showed that Glu measures from
locally applied Glu were not significantly different throughout the first seven days
post-implantation in a given brain region. Additionally, exogenous Glu measures
in the PFC of Long Evans and Fischer 344 rats were significantly increased
compared to the striatum in the respective rat strain.

Also, exogenous Glu

measures in the PFC were significantly increased in Long Evans rats compared
to Fischer 344 rats.

However, no difference was observed in the striatum

between the two rat strains.

These observations show that there were

differences in the clearance of Glu between brain regions and rat strains. These
differences in clearance may be due to potential differences in brain tissue
morphology, either the density of tissue or the type of cells present, or
differences in the number, location, or efficiency of the Glu transporters. We also
examined changes in clearance in the PFC of Fischer 344 rats and observed a
trend in increased clearance time associated with longer implant durations.
These results also show that our enzyme-based ceramic MEA can reliably
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measure Glu when chronically implanted in the brain for at least one week postimplantation.
In Chapter Five we examined the extent of damage, measured by
astrocyte density and activated microglia, caused by chronic implantation of our
ceramic MEAs in the PFC of Long Evans rats. GFAP staining showed that there
were no significant changes in astrocytes in rats with chronic MEA implantations
for up to eight weeks. However, at 16 and 24 weeks post-implantation there was
a significant increase in GFAP density. There was also a significant increase in
mean density ionized calcium binding adaptor molecule 1 (Iba1) at the 1 week
time point.

However, the Iba1 levels return to control levels by 24.

In all

implantation durations examined, astrocytic changes indicating damage were
contained to within 50-100 µm from the implantation site. These results show
that chronic implantation of our ceramic MEAs caused minimal damage to
surrounding tissue and the electrode was well tolerated by the host for an
extended length of time. Furthermore, the results support that as we improve
upon the technology and methodology of our enzyme-based coating, we will be
able to extend the duration that we accurately and reliably measure Glu in the
CNS.
In Chapter Six we applied our newly developed technology in freely
moving rats to a behavioral paradigm in an effort to enhance the current
understanding of the affects of stress on Glu levels in the striatum and PFC of
Fischer 344 and Long Evans rats. Our results show that while there was no
significant difference in the maximum Glu amplitude elicited between brain
regions or rat strain, the duration of the Glu response observed in the striatum
and PFC of Fischer 344 was significantly increased compared to that seen in the
striatum and PFC of the Long Evans rats. An analysis of the Glu response vs.
time showed no significant difference in the tail-pinch response area under the
curve. However, there was a trend with the PFC showing elevated levels as
compared to the striatum in both rat strains. These results suggest that there
may be multiple short-lived Glu peaks above the general rise and fall of the tailpinch response, not just a single maximum amplitude peak.

9

The number of

peaks during the tail-pinch response showed an increased trend in the PFC of
both rat strains compared to the striatum. This supports the need for a technique
with high temporal resolution that is capable of distinguishing fast fluctuations in
Glu coupled with advanced analytical techniques that can accurately depict
changes of fast neurotransmitters, such as Glu.
Copyright © Erin Cathleen Rutherford 2007
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Table 1.1: Distribution of the Rat Brain Excitatory Amino Acid Transporters

Transporter Subtype

Primary Localization

GLAST-1

Astrocytes

GLT-1

Astrocytes

EAAC

Postsynaptic neurons

EAAT4

Cerebellar Purkinje neurons (human)

EAAT5

Retina (human)
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Table 1.2: Ionotropic Glutamate Receptors

Ionotropic Receptors
Select Agonist
Functional
Characteristics
Other Agonists

NMDA

AMPA

Kainate

NMDA

AMPA

Kainate

Activation of NA+,

Activation of

Activation of

K+, and Ca2+

NA+, K+, and

NA+, K+, and

channels

Ca2+ channels

Ca2+ channels

Ibotenate,

Quisqualic acid

Domoate,

2-AP5

CNQX, DNQX

CNQX, DNQX

Glycine,

Benzothiazide A

concanacalin

D-serine

(Con A)

quinolinate
Competitive
Antagonists
Allosteric Modulators
Antagonists on

5,7-diCl-Kyn

allosteric binding
sites
Channel Blockers

PCP,

Jorospider toxin

MK-801

(JST)

2-AP5, 2-amino-5-phosphonopentanoic acid; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione;
DNQX, 6,7-dinitroquinoxaline-2,3-dione; 5,7-diCl-Kyn, 5,7-dichlorokynurenic; PCP, phencyclidine;
MK-801, dizocilpine.
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Group III

Group II

Group I

Table 1.3: Metabotropic Glutamate Receptors
Receptor

Coupling

Localizations and Functions

Agonists

Antagonist

mGluR1

Gq;
increase
PLC

primarily postsynaptic in neurons; activation
enhances postsynaptic glutamatergic excitability

3,5-DHPG
quisqualate

CPCCOEt
(noncompetitive)

mGluR5

Gq;
increase
PLC

Primarily postsynaptic in neurons and glia

mGluR2

Gi, Go;
decrease
AC

Pre- and postsynaptic in neurons; high expression
levels in rat forebrain

mGluR3

Gi, Go;
decrease
AC

Primarily postsynaptic in neurons and glia

mGluR4

Gi, Go;
decrease
AC

Pre- and postsynaptic in neurons; high expression
levels in rat cerebellum

mGluR6

Gi, Go;
decrease
AC

Localized to retinal tissue; low expression in brain
tissue

mGluR7

Gi, Go;
decrease
AC

Pre- and postsynaptic in neurons; targeted
presynaptically to active zone of glutamate release

mGluR8

Gi, Go;
decrease
AC

Pre- and postsynaptic in neurons; negative
modulation of glutamate

MPEP
(noncompetitive)
DCG-IV
2R,4R-APDC
LY354740
LY379268

EGLU
LY341495
LY307452

L-AP4
L-SOP
PPG
3,4-DCPG is
a selective
mGluR8
agonist

CPPG
MAP4

3,5-DHPG, 3,5-dihydroxyphenylglycine; CPCCOEt, 7-hydroxyiminocyclopropane[b]chromen-1acarboxylic acid ethyl ester; MPEP, 2-methyl-6-(phenylethynyl)-pyridine; DCG-IV, (2S, 2’R,3’R)-2(2’,3’-dicarboxycyclopropyl)glycine; 2R,4R-APDC, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic
acid; EGLU, (S)-α-ethylglutamic acid; L-AP4, 1,2-amino-4-phosphonobutyrate; L-SOP, S-serineO-phosphate;
PPG,
(RS)-4-phosphonophenyl
glycine;
CPPG,
(2S,2’R,3’R)-2-(2’,3’dicarboxycylcopropyl)glycine;
MAP4,
(S)-α-methyl-2-amino-4-phosphonobutanoic
acid.
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Glutamatergic Neuron

Glutamine
Glutamine

Glutamate

α-ketoglutarate
Glutamate
Alanine
Pyruvate

Pyruvate

Krebs
Cycle

Alanine
α-ketoglutarate

Krebs
Cycle

Alanine Amino
Transferase
Glutamate
Dehydrogenase
Glutaminase

Glia Cells and Astrocytes

Glutamine
Synthetase

Figure 1.1: Neuronal Glutamate Metabolism Schematic
Schematic showing basic Glu metabolism and release at a glutamatergic synapse.
Glutamatergic neurons release Glu derived from glutamine and the Krebs Cycle into the synaptic
cleft. Glu is taken up into glial cells where it is converted to glutamine. Glutamine can then be
transported to the glutamatergic neuron where it can be deamidated back into Glu and packaged
into synaptic vesicles for release. In glia, Glu from the Krebs Cycle can also be converted into
glutamine and transported to glutamatergic neurons where it can be converted back into Glu for
release. Adapted from Waagepetersen et al., 2000.
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m
Gl
uR
3

GABAB

1/5
luR

mGluR4/8

/8

EAAC

mG

4
luR
mG

GABAB

Presynaptic
NMDA

Postsynaptic
↓cAMP

↓Cl-

↑Ca2+

AMPA

vGluT

Modulation
of excitation

↑Na+
Kainate

luR
2/3

mGluR7

mG

GLT-1/
GLAST-1

mGluR1/5

Krebs Cycle

GABAA

mG
luR
7

mGluR3 Cys/Glu
mGluR5

↓cAMP

mGluR3
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and Astrocytes

Glutamine
???

Glutamate
GABA

Figure 1.2: Glutamatergic Synapse Schematic
Schematic representation of a typical glutamatergic synapse. Glu from the Krebs Cycle is loaded
into synaptic vesicles by vGluTs. The synaptic vesicles fuse with the neuronal membrane
releasing Glu into the synaptic cleft. Glu can be transported into postsynaptic neurons via EAAC
and into glia via GLT-1 and GLAST-1. Glu in the synaptic cleft can induce downstream signaling
via post-synaptic neurons through mGluRs (groups I, II, and III) as well as through iGluRs
(NMDA, AMPA, and kainate). Glu can excite or inhibit presynaptic neurons through mGluR
groups I, II, and III. mGluR group I and II as well as the cystine-Glu exchanger are located on
glia. GABAergic neurons, which can be influenced by mGluR group II and III, can also act on
postsynaptic neurons through GABAA and GABAB receptors. Adapted from Schoepp, 2001.

15

Chapter Two: Materials and Methods
Microelectrode Array Design and Fabrication
Our multisite microelectrodes were constructed in conjunction with Thin
Films Technology, Inc. (Buellton, California).

In these studies, MEAs were

produced with the desired recording site array layout (S2 microelectrode arrays
consisting of four (two side-by-side pairs) Pt recording sites, each 15 x 333 µm).
Microelectrode photographic masks were designed on a computer aided design
program where arrays of 4 recording sites were arranged on templates. A 2.5 x
2.5 cm x 125 µm thick ceramic wafer (alumina, Al2O3, Coors Ceramic, Coors
Superstrate 996) served as a substrate for the MEAs. Ceramic was used for its
ability to reduce cross-talk from adjacent connecting lines. Ceramic also allowed
for stereotaxic placement into tissues without flexing or breaking due to ceramic’s
strong and rigid nature.
The ceramic wafer was cleaned and a photoresist was spun onto the
wafer.

Light passing through the photomask exposed the photoresist,

transferring the microelectrode images onto the wafer. Spaces for the recording
sites, connecting lines and bonding pads were not exposed to light. Unexposed
photoresist was removed from the wafer using solvents. Titanium (500 Ǻ thick)
was sputtered onto the ceramic wafer that was covered with developed
photoresist. The titanium acted as an adhesion layer that helped the Pt adhere
to the ceramic substrate. The active recording metal layer, Pt, was sputtered
onto the substrate (~1.5 μm thick) on top of the titanium adhesion layer. Next,
the developed photoresist and unwanted metals were removed with solvents
resulting in the ceramic wafer covered only with the Pt recording sites and
connecting lines. Finally, a protective polyimide layer (2-4 μm thick) was applied
using a second photomask step, leaving the 4 active Pt recording sites uncoated.
The individual microelectrodes tips were cut out using a diamond saw, which
produced highly polished edges for reduced tissue damage during implantation.
The ceramic wafer with Pt recording sites was attached to a small printed circuit
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board (PCB) that allowed for easy handling and modification for use in the freely
moving rat.
Microelectrode Preparation
Exclusion Layer
Microelectrodes were coated with an exclusion layer to block undesirable
electrochemically active compounds that exist in high concentrations in the brain.
The Pt recording sites were dip coated with the exclusion layer, Nafion® (an
anionic Teflon® derivative with negatively charged sulfonic acid groups), which
acted to repel anions, such as ascorbate and DOPAC (Burmeister and Gerhardt,
2001). This was accomplished by first aliquoting Nafion® into a 300 μl centrifuge
tube. The microelectrode tip was then lowered approximately half-way into the
aliquot of Nafion® and rotated in a circle three times and the tip was pulled
straight out of the Nafion® solution. Microelectrodes were then placed in an oven
at 165-175°C for five minutes to allow the Nafion® layer to cure on the tip.
Microelectrodes were allowed to cool to room temperature for approximately 30
minutes prior to enzyme coating.
Enzyme-Based Microelectrode Design
Enzymes provided a means to convert a molecule, such as Glu, that is not
inherently electrochemically active and therefore not measurable by a 16 bit Fast
Analytical Sensing Technology (FAST-16) recording system (Quanteon, LLC,
Nicholasville, KY), into a reporter molecule, such as peroxide (H2O2), that is
oxidizable at the Pt recording sites of the microelectrodes.

The current

measured from the oxidation of peroxide generated during the enzymatic
breakdown was directly proportional to the analyte (Glu) concentration.
Microelectrode recording sites 1 and 2 (the lower pair) were coated with a 1%
Glu oxidase (GluOx) coating solution. In order to induce cross-linking of GluOx
and increase the adhesion of GluOx to the Pt recording sites, glutaraldehyde
(0.125%) and BSA (1%) were added to the GluOx solution. To prepare the
GluOx solutions, first, all proteins were brought to room temperature and 0.10 g
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of bovine serum albumin (BSA) was dissolved by manual agitation in a 1.5 mL
microcentrifuge tube containing 985 μl ddH2O. Once dissolved, glutaraldehyde
solution (5 μl) was added to the BSA mixture and manually mixed by inversion
five times. The solution was set aside for five minutes. The BSA served as a
matrix to protect the oxidase enzyme activity during immobilization. Next, the
BSA/glutaraldehyde mixture (9 μl) was added to a 300 μl microcentrifuge tube
and 1 μl of the Glu stock solution (1 UI/μl) was added and mixed by pipette
agitation.
All enzymes were applied to the Pt recording sites by hand. Solutions
were drawn up into a 10 μl Gastight® Hamilton microsyringe and dispensed to
form a single small droplet of solution at the tip of the microsyringe. The droplet
was briefly applied to the Pt recording sites under a dissecting microscope. Two
additional coats of enzyme were applied in the same way with one minute dry
times between each coat. The GluOx layer was required by our approach to
measure Glu, as it caused the enzymatic break-down of Glu to α-ketoglutarate
and H2O2. When a potential of +0.7 V vs. a Ag/AgCl reference electrode was
applied to the MEA, the reporter molecule, H2O2, was oxidized and donated two
electrons and the resulting current was then amplified and recorded by the
FAST-16 recording system.
The advantage of using multisite microelectrodes was that a pair of
recording sites were coated with the enzyme mixture and the adjacent sites were
coated with the inactive protein matrix (BSA and glutaraldehyde) in the same
manner as applying the enzyme mixture. Our laboratory refers to this technique
as “self-referencing”. Microelectrode recording sites 3 and 4 (self-referencing or
sentinel sites) were coated similar to sites 1 and 2, with the exception that the
coating solution did not contain GluOx (Figure 2.1). This means that sites 3 and
4 recorded everything not repelled by Nafion® (any possible interferents, etc.)
except Glu.

When the current from sites 3 and 4 were subtracted from the

current on sites 1 and 2, the resulting signal was due solely to Glu (Burmeister
and Gerhardt, 2001 & Burmeister et al., 2003). The combination of the exclusion
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layer and the self-referencing technique resulted in a microelectrode with minimal
background noise and an increased selectivity for the analyte of interest, Glu.
Once

the

microelectrodes

enzyme
were

and/or

stored

at

inactive
room

protein

matrix

temperature.

was

applied,

Enzyme-coated

microelectrodes cured at room temperature for 48-72 hours prior to calibration
and experimentation. Complete curing increased enzyme layer adhesion to the
microelectrode surface.

This provided increased sensitivity to Glu as well as

increased the shelf-life of the microelectrodes. If the enzyme/protein layers were
not allowed to fully dry, they might have dissolved when put into solution or the
brain and the maximum number of possible chronic Glu recording days may have
been diminished.
Reference Electrodes
Ag/AgCl reference electrodes were prepared by first stripping the Teflon®
coated silver wire (0.08 in bare, 0.110 in coated; A-M Systems, Inc., Carlsborg,
WA) ¼ inch on each end. One of the stripped ends was soldered to a goldplated socket (Ginder Scientific, Ottawa, ON) for connection to the FAST-16
headstage for freely moving recordings and the other end was coated with AgCl
by placing the tip of the stripped sliver wire (cathode) into a 1 M HCl plating bath
saturated with NaCl containing a Pt wire (anode) and applying 9 V DC current
using a power supply to the cathode vs. the anode.

The applied potential

attracted Cl- on the wire to form AgCl thus making the Ag/AgCl reference. The
plating potential was applied for approximately 10-15 minutes.
Printed Circuit Board Modification
The pedestal was the portion of the system that was chronically implanted
on the rat’s head and contained the microelectrode. The pedestal connected to
the miniaturized rat hat, which contained the miniature 4-channel pre-amplifier
that was connected to a low torque commutator. The PCB was altered during
MEA production to change the electrode PCB from the design used in slice and
anesthetized animal recordings to a smaller design required for use in freely

19

moving animals. The resulting shorter paddle was termed “stub” (Figure 2.1).
The stub MEA was designed to allow for future advances to the MEAs with up to
16 individual recording sites. The number of recording sites can be changed
simply by using the same stub PCB and substituting a ceramic tip with a different
configuration. The ceramic-based Glu MEAs were prepared for freely moving
recordings first by cleaning the MEA.

This was done by dipping the bottom

portion of the ceramic electrode tip in filtered, stirred isopropyl alcohol for five
minutes. This was followed by a five minute wash with stirred ddH2O to aid in
removing any residues from the recording sites. The Pt recording surfaces were
carefully wiped twice with Kimwipes® to further remove any residual particles that
may be on the recording sites and would have hindered the adhesion of the
enzyme matrix. MEAs were dried for fifteen minutes at 105-115°C to ensure
there was no residual water on the sites. Next, the MEAs were coated with
Nafion®, cured at 170 ºC for five minutes followed by applying the coating
solutions (either containing or not containing GluOx) as described previously.
Chronic Connector and MEA Attachment
In order to attach the chronic connector to the modified MEA for freely
moving recordings, connecting wires were prepared by first stripping both ends of
30 AWG varnished copper wire (Radioshack). One end of the copper connecting
wire was soldered to a gold-plated socket (Ginder Scientific, Ottawa, ON). The
other end of the wire was soldered to the PCB for each of the four corresponding
recording sites, using eutectic solder, a low heat soldering iron (200° C) and heat
sinks to prevent heat transfer damage to the enzyme matrix on the Pt recording
sites (Figure 2.1). The PCB portion of the microelectrode was coated with water
proof five-minute epoxy to secure the assembly and protect the interface from
moisture. The epoxy was allowed to dry for approximately one hour. The goldplated socket ends of the reference and microelectrode wires were inserted into
a 9 pin miniature connector (Ginder Scientific, Ottawa, ON) so that the sockets
were completely encompassed by the connector. The varnished copper wires
were tucked around the miniature connector and the MEA tip was carefully
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positioned parallel to the miniature connector. Correct positioning of the MEA tip
was essential for accurate stereotaxic placement in the brain. Water proof fiveminute epoxy was used to secure the paddle and wires to the miniature
connector, making sure that the exposed part of the sockets on the end of the
connector closest to the microelectrode tip and wires were covered with epoxy to
ensure that moisture did not penetrate the pedestal. The completed assembly
was allowed to air dry for at least 1 hour.
Microelectrode Array /Cannula Assembly
In order to locally apply small quantities of Glu and other pharmacological
agents near the MEA tip, a 26-gauge stainless steel guide cannula with inserted
dummy cannula (Plastics One, Roanoke, VA) was attached to the PCB so the tip
of the dummy cannula, protruding 1 mm past the guide cannula, was aimed
between the four recording sites at a distance of approximately 100 µm away
from MEA tip. This was accomplished by attaching modeling clay to the PCB
and using the modeling clay to hold the guide cannula steady while it was
positioned between the recording sites. Once the guide cannula was properly
positioned, it was held more firmly in place by applying melted Sticky Wax (Kerr
Corp., Orange, CA) onto the PCB and encasing the modeling clay. Since the
MEAs were coated with Nafion® and once they have been soaked the tips had to
remain wet to prevent cracking in the exclusion layer, the guide cannula were
attached pre-calibration. Local applications of Glu or drug solutions for local
pharmacological studies of the CNS were performed through a 33-gauge internal
cannula, which protruded 1 mm past the guide cannula. A stainless steel dummy
cannula remained in the guide whenever the animal was not in the recording
chamber (Figure 2.1).
Electrode Calibration
Pt recording sites on the microelectrodes may respond differently to
peroxide and Glu, and therefore must be calibrated in vitro prior to chronic
implantation to determine standard curves.
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These calibrations were used to

equate a change in current from the oxidation of peroxide to a proportional
change in Glu (analyte) concentration. Calibration also allowed us to determine
the individual Pt recording sites sensitivity and selectivity against ascorbic acid, a
major interferent in the brain. Constant potential amperometry was performed
using a FAST-16 system designed for recording simultaneously from the fourchannel microelectrodes with a primary gain of 0.2 nA/V and secondary gain of
10 X generating a final gain of 2 nA/V for all calibrations.
Nafion® coated microelectrode tips were soaked in a solution of 0.05 M
phosphate buffered saline (PBS) for at least one hour prior to calibration. The
soaking time allowed for better diffusion of analytes through the Nafion® layer as
well as activation of the enzyme layer. However, once the Nafion® coated MEA
has been wet, it must remain in solution at all times. If the soaked Nafion®
coated MEA was allowed to dry, the Nafion® layer would crack, allowing
interferents to pass through the exclusion layer, therefore, decreasing the
selectivity of the Pt recording sites for Glu.
After soaking the MEA tip for at least one hour, the tip of the modified
MEA was placed in a continuously stirred solution of 0.05 M PBS (40 mL; pH 7.4)
using a battery operated, portable magnetic stir plate (Barnant Co.).

A

recirculating water bath (Gaymar Co.) was used to maintain a constant buffer
temperature of 37ºC to allow the enzyme layer to function properly and to mimic
physiological conditions. The calibrations were operated at a constant applied
potential of +0.7 V vs. a Ag/AgCl reference electrode, allowing approximately 15
minutes prior to the addition of calibration solutions for the current to reach a
stable baseline.

Calibrations were performed by achieving final buffer

concentrations of 250 µM ascorbic acid and 20, 40, and 60 µM Glu through
additions of aliquots of 20 mM ascorbic acid and 20 mM Glu stock solutions
(prepared in ddH2O) and allowing for stable baseline conditions between each
addition. Also, after the final addition of Glu was added, two test substances, 2
mM DA (2 μM, final beaker concentration) and 8.8 mM H2O2 (8.8 μM, final
beaker concentration) (40 µL additions; made in ddH2O), were added. The test
substances were used to determine the relative response and sensitivity of the
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individual Pt recordings sites on each MEA and if needed, could be used as a
means to normalize the experimental data. The test substances did not affect
the calibration slope, or any calculations derived from the slope (Figure 2.2).
Another test substance addition was performed when a new substance was to be
used for local or systemic application experiments to ensure that the compound
was not electrochemically active on the Pt recording surfaces at +0.7 V. The
FAST-16 system software recorded the current for each addition of analyte (Glu),
created a calibration curve for each Pt recording site, and stored the slope of this
calibration.

Selectivity ratios for Glu over ascorbic acid were calculated in

addition to the slope (sensitivity), limit of detection (LOD), and linearity (R2) for
MEA Pt recording sites coated with GluOx.

Due to the highly reproducible

fabrication process of the MEA, Glu responses were extremely linear and were
only used if linear regression curves fit with R2 ≥ 0.99.
Sensitivity of the MEA corresponded to how well the change in Glu was
measured. The slope from the in vitro calibration was used to equate a change
in current to a change in Glu concentration and can be applied to determine the
Glu concentration in vivo. The slope was also used to calculate LODs, which
were the main criteria used to select microelectrodes.

LOD is the limit of

detection for the MEA and was defined as the analyte concentration that resulted
in an electrode response that was equivalent to 3 times the background noise of
the FAST-16 recording system. This was a conservative determination of the
lowest detectable change in analyte concentration that cannot be attributed to
noise. The LODs for our microelectrodes range from approximately 0.2 to 1.0
μM, depending on the stability of the sites. Our laboratory normally recommends
using MEAs with LODs ≤ 1 μM, depending on the expected Glu response,

with 0.2 µM being optimal.
Selectivity refers to the ratio of the microelectrodes sensitivity for Glu over
interferents, such as AA. Selectivity was determined by dividing the Glu slope by
the AA slope. A MEA with a selectivity of 100:1 refers to a 100 μM concentration
increase of AA results in an apparent 1 μM concentration increase in Glu, or that
the MEA is 99% effective at blocking AA. Selectivity ratios of 100:1 or greater

23

are ideal, however, selectivity ratios as low as 20:1 were still used and extremely
effective since this ratio is not a linear correlation. In vitro calibrations showed
that slope and LOD values were not significantly different over 7 days (Figures
2.3 and 2.4).
Animal Preparation for Awake Freely Behaving Amperometric Recordings
Male Long Evans or Fischer 344 (Harlan) rats 3-6 months of age at the
time of surgery were used for all experiments. Fischer 344 rats weighed 375-450
g, while Long Evans rats weighed 400-600 g at the time of surgery. The animals
were group housed in a 12 hour light/dark cycle with free access to food and
water in the AAALACI-approved animal resource center at the University of
Kentucky. Animals were allowed at least 7 days to acclimate to the environment
prior to any experiments. All appropriate animal care (food, water, bedding, cage
cleaning, etc.) was performed by the Animal Resource Center staff. There were
no procedures involving undue discomfort to the animals. Following surgery, rats
were individually housed under the same conditions. Animal care was approved
by the University of Kentucky Institutional Animal Care and Use Committee and
was in accordance with the Guide for the Care and Use of Laboratory Animals.
Electrode implantation
Following a successful calibration of the microelectrode, rats were
anesthetized with 2% isoflurane, and placed in a stereotaxic apparatus (Kopf
Instruments, Tujunga, CA). Animal body temperature was maintained at 37°C
with an isothermal heating pad (Braintree Scientific, Braintree, MA).

The

animals’ eyes were coated with artificial tears (The Buttler Company, Columbus,
OH) to help maintain moisture and prevent infection.

All surgeries were

performed in a Vertical Laminar Flow Workstation (Microzone Corp., Ottawa,
ON), which filtered lab air through a HEPA filter.

Prior to incision, the skin

directly on top of the animals head (between the ears and from just behind the
eyes to the neck) was wiped with Betadine solution to keep the incision area
clean and to prevent infection. The skin on top of the rat’s head was reflected,
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making as small an incision as possible. Three small holes were drilled in the
skull in the opposite quadrants of where the MEA was implanted for placement of
stainless steel skull screws.

A fourth hole was drilled contralateral from the

recording site for insertion of the Ag/AgCl reference electrode (see above). The
animals underwent a 2 mm x 2 mm craniotomy and were implanted with a Glu
selective MEA pedestal assembly into the right striatum (AP: +1.0 mm; ML: -2.5
mm; DV: -4.3 mm vs. bregma) or the right prefrontal cortex (AP: +3.2 mm; ML: 0.8 mm, DV: -4.5 mm vs. bregma), based on the coordinates from Paxinos and
Watson (2005) with the incisor bar set so that the skull was level (-2.3 mm).
Three small stainless steel screws (Small Parts, Inc) were threaded into the skull
to serve as anchors and care was taken so that the tip of the screw did not touch
the brain (Figure 2.5). The assembly was secured with approximately four layers
of dental acrylic (Lang Dental MFG, Wheeling, IL), taking care to cover as much
of the MEA assembly as possible. The dental acrylic had a smooth texture and
care was taken to remove excess dental acrylic from the fur surface so as not to
promote the rat to scratch its head.
Following surgery, rats were placed in their cage and monitored until the
rat recovered from anesthesia (rats were usually fully awake within 5-10 minutes
after removing from isoflurane).

One subcutaneous injection of Rimadyl®

(carprofen) sterile injectable solution (10 mg/kg) (Pfizer, New York) was
administered immediately following surgery for post-surgery inflammation and
pain. Rats were allowed to recover for a minimum of two days prior to initial
recordings.
Awake Freely Behaving Recordings
Recording Apparatus
The recording apparatus consisted of a large wooden box with a
Plexiglas® insert.

The recording headstage consisted of a round miniature

connector with 5 connector pins (one connecting each of the four Pt recording
sites and one connecting the Ag/AgCl reference electrode). The connector pins
lead to the 4 channel low noise potentiostat (Rat Hat 4, Quanteon, LLC,
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Nicholasville, KY), which once connected sat as close as possible to the animal
in order to minimize noise artifacts.

The potentiostat created a potential

difference between the microelectrode array and a reference electrode to
carryout electrochemical recordings.

Connecting wires, encompassed by an

insulator, lead to the low torque commutator at the top of the box. The recording
assembly hung from the top center of the box from a 12 lead commutator
(Airflyte, Bayonne, NJ). This allowed the animal to freely move to all areas of the
box. The outputs of the commutator were connected to the FAST-16 system
where the electrochemical analog signals generated by oxidation reactions were
amplified and then digitized in the FAST-16 microcomputer using a fast A/D-D/A
board (National Instruments) (Figure 2.6).

In addition, control voltages for

amperometric measurements were controlled by the data acquisition board. The
digitized second-by-second (1 Hz) representation of the data was then visualized
and recorded using the FAST-16 software (Quanteon, LLC, Nicholasville, KY).
Recorded files were exported to other Windows™ based applications, such as
Excel™, for easier data processing.
Recording protocol
Typical recording sessions involved allowing the rat to freely roam around
the recording chamber for ten minutes to acclimate to the surroundings before
connecting the pedestal to the potentiostat. Data acquisition was started and the
rat underwent a minimum thirty minute acclimation period, or until baseline was
stabilized,

before

an

ejection

cannula

was

inserted

or

animal

manipulations/behavior studies were initiated. At this point, resting, or basal, Glu
measures were taken. The ejection cannulae were only inserted on days when
chemicals needed to be ejected.

After the ejection cannula was inserted

(connected to a 10 µL Hamilton syringe), another acclimation period of ~ 30
minutes was allowed so that baseline was again established.

Following this

period, the effects of locally applied Glu, urethane injections (i.p.), or other
compounds, or a 5 minute tail-pinch were studied for up to three additional hours.
The volumes of locally applied Glu were kept constant at 1 µL.
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Following completion of the experiments (after multiple days of
recordings), rats were anesthetized with isoflurane and transcardially perfused
with 0.9% saline followed by 4% paraformaldehyde. The brain was removed and
stored in 4% paraformaldehyde for three days followed by storage in 0.1 M
phosphate buffer (10% sucrose) for sectioning and staining to confirm MEA
placement and examining possible tissue damage.
Histopathology
Male Long Evans rats between the age of 3 and 6 months at the time of
surgery were chronically implanted with pedestal microelectrodes as previously
described. Animals were then anesthetized with isoflurane and transcardially
perfused after 1, or 3 days, 1, 2, 4, 8, 16, or 24 weeks. The brains were stored as
previously described. After rinsing in sucrose, cryostat sections (14 µm) were
collected from the area of implantation. The sections were postfixed in acetone
for 3 minutes prior to being processed for indirect immunohistochemistry.
Antibodies used were raised against glial fibrillary acidic protein (GFAP antimouse, diluted 1:400; Chemicon) as a marker for astrocytes and Iba1 (antirabbit, diluted 1:1000; Wako Chemicals, Germany), a pan-microglia marker (Imai
et al., 1996; Ito et al., 1998). Incubations were performed for 48 hours at 4°C.
After washing, the sections were incubated in Alexa 488 and Alexa 594
secondary antibodies (diluted 1:500, Molecular Probes) for 1 hour at room
temperature. Antibodies were diluted in PBS containing 0.3% Triton-X. After
additional rinsing the sections were mounted in 90% glycerin in PBS. Double
labeling of GFAP and Iba1 were performed in sequence such that each type of
antibody was applied one at a time. Sections were evaluated using image
analysis and Improvision software. The densities of GFAP and Iba1
immunoreactivities were calculated using NIH image software on binary images
and expressed as mean grey density. Mean values from four sections from each
brain were analyzed using a one-way ANOVA followed by Tukey’s post hoc
analyses. All measurements were performed on blind-coded slices.
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Drugs and Reagents
All chemicals were used as received unless otherwise stated.
Electrode Preparation and Calibration
Nafion® (5% in a mixture of aliphatic alcohols and water), BSA,
glutaraldehyde, ascorbate, Glu monosodium salt, and 3-hydroxytrypamine HCl
(dopamine, DA) were obtained from Sigma-Aldrich Corp. (St. Louis, MO). GluOx
was purchased from Seikagaku America, Inc. (East Falmouth, MA). The 3%
H2O2 solution was purchased from a local retailer. 0.05 M PBS was created using
sodium chloride, sodium phosphate monobasic, and sodium phosphate dibasic
obtained from Fisher Scientific.

The DA stock solution was prepared in 1%

perchloric acid for prolonged stability. Glutaraldehyde was stored at -20 ºC.
Special care was taken to ensure that the stock Nafion®, BSA, and
glutaraldehyde solutions were only used for 1-2 months.

All solutions were

prepared using distilled water, which was de-ionized using a Millipore® water
treatment system.
Intracranial Ejection
All solutions administered intracranially were prepared in 0.9%
saline solution, adjusted to pH 7.4, and filtered prior to use through a sterile
syringe filter (0.22 µm pore size, Costar, Corning, NY). All components of the 5
mM Glu, 0.9% saline solution, 4% paraformaldehyde, 0.1 M PB with 10%
sucrose, were purchased from Fisher Scientific.
obtained

from

Sigma-Aldrich

Corp.

(St.

Tetrodotoxin (TTX) was

Louis,

MO,

USA).

(S)-4-

carboxyphenylglycine (CPG) was obtained from Tocris Cookson Inc. (Ellisville,
MO).

mGluR agonist (LY379268) and mGluR antagonist (LY341495) were

obtained from Eli Lilly & Co. (Indianapolis, Indiana).
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Anesthetics and Special Use Drugs and Chemicals
Isoflurane, used as anesthetic for recovery surgery and perfusions, was
obtained from Baxter Pharmaceutical. Rimadyl®, used for post-operative pain
and inflammation, was obtained from Pfizer.
Data Analysis
The FAST-16 recording system saved amperometric data, time, and
ejection data marks for all four recording channels. Unless otherwise noted,
calibration data, in conjunction with a modified spreadsheet program, was used
to determine parameters for the signal differences recorded between data marks.
Measures derived from the data file included maximum amplitude, measured
from baseline to the peak concentration of the signal, the time in seconds, or
duration, of the signal, and t80, or the time it takes for 80% of the signal to decay.
Unless otherwise noted, ejection (local application) volumes remained constant
at 1 µL. Additionally, for stress-evoked Glu measures, area under the curve was
calculated from the beginning of the tail pinch until the Glu levels returned to
baseline measures. An analysis of variance (ANOVA) with a Tukey’s post hoc
test was used to analyze the significance of all data. Significance was defined as
p < 0.05.
Copyright © Erin Cathleen Rutherford 2007
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Figure 2.1: Freely Moving Microelectrode Design
A) Stub PCB with attached ceramic tip, or the stub MEA. B) Stub MEA with connecting copper
soldered to stub at the positions for channels 1, 2, 3, and 4. Gold-plated sockets are attached to
the ends of the copper wire. Only the varnished section of the copper wire is showing. C)
Photograph of the pedestal MEA consisting of the stub MEA, Ag/AgCl reference electrode, and
miniature connector. Epoxy was used to mount the stub MEA on the miniature connector. D)
Pedestal MEA with attached guide cannula. Dummy cannula is inserted in the guide cannula and
protrudes past the guide cannula. The guide cannula is held in place with sticky wax. E)
Illustration showing a Nafion® coated self-referencing MEA. Pt recording sites are 333 x 15 µm
with 20 µm/100 µm spacing. E1,2) Glu recording sites. E3,4) Self-referencing sites. Adapted
from Rutherford et al., 2007.
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Figure 2.2: L-Glutamate Self-Referencing Microelectrode Array Calibration
Representative tracing of a typical calibration of a self-referencing Glu selective pedestal MEA. A
single 500 µL addition of 20 mM ascorbate shows little to no change in current. This was
followed by three 40 µL additions of 20 mM Glu yielding a linear increase in Glu response on the
GluOx coated sites (channels 1 and 2) but not the self-referencing sites (channels 3 and 4). DA
(2 mM) and H2O2 (8.8 mM) were added (40 µL) as test substances and changes in current were
measured on all four recording sites.
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Figure 2.3: Slope Values for In Vitro Calibrations
In vitro calibrations were performed on MEAs to determine their slope values over days. MEAs
were Nafion® coated and continuously soaked in 0.05 M PBS. Slope values were not significantly
different over 7 days of calibration.
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Figure 2.4: Limit of Detection Values for In Vitro Calibrations
In vitro calibrations were performed on MEAs to determine their LOD values over days. MEAs
were Nafion® coated and continuously soaked in 0.05 M PBS. LOD values were not significantly
different over 7 day calibrations.
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Figure 2.5: Microelectrode Implantation Surgery
Drawing of rat skull (left) and schematic of pedestal MEA implantation surgery in the right PFC of
a Long Evans rat (right). Three skull screws were threaded into the skull (blue), a hole was drilled
for placement of the reference electrode (green), a separate larger hole in the shape of a
rectangle was drilled for MEA placement and the skull section was removed. Adapted from
Paxinos and Watson, 2005.
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Figure 2.6: Schematic Diagram of the In Vivo Freely Moving Recording System
The pedestal MEA is implanted in to the rat brain. When the MEA is connected to the FAST-16
recording system, the signal travels from the implanted MEA to the pre-amplifier rat hat. The
signal then travels through the commutator, which is located at the top of the recording chamber,
and finally in to the FAST-16 control box and PC workstation. The commutator allows for the
connecting wires to freely rotate as the rat moves throughout the recording chamber without
hindrance. Gold sockets from the miniamplifier/rat hat connect to the gold sockets embedded in
the miniature connector of the pedestal to allow for continuous recordings. Dental acrylic
surrounds the implanted pedestal apparatus. The rat is able to move to all areas of the recording
chamber, performing everyday activities while Glu is simultaneously recorded from the CNS of
the rat. Rutherford et al., 2007.
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Chapter Three: Resting L-Glutamate Measures in Awake Male Fischer 344 and
Long Evans Rats
Introduction
Resting Glu measures in awake animals have been established using
microdialysis; however, this method may not be capable of detecting subtle
second-by-second changes in neuronal Glu and the origin of the glutamatergic
pool being sampled is controversial. Additionally, resting levels may be altered
through a variety of mechanisms, including the effects of anesthesia.
Anesthetics, including urethane, have been shown to decrease neuronal activity
(Albrecht and Davidowa, 1989; Dyer and Rigdon, 1987; Girman et al., 1999)
while maintaining excitatory Glu-mediated synaptic signal transmission (Sceniak
and MacIver, 2006).

More specifically, previous studies have reported on

reduced tonic Glu levels in anesthetized preparations (Liachenko et al., 1998,
1999).

Urethane, the anesthetic currently used in our laboratory for acute

recordings, was initially used because it was believed to have minimal affects on
DA signaling, also of interest to our laboratory. However, little is known as to
how urethane affects glutamatergic neurotransmission. There is precedence that
anesthetics affect Glu neurotransmission in vitro; isoflurane was shown to
decrease activation of both NMDA and non-NMDA glutamatergic receptors as
well as reversibly reduce field potentials (Ranft et al., 2004).
Little is known about potential mechanisms involved in regulating resting
Glu and Glu release, such as the role inhibitory autoreceptors play in Glu
signaling. There is evidence that supports the involvement of Glu receptors,
specifically mGluRs.

Some mGluRs have been shown to act as inhibitory

presynaptic autoreceptors (groups II and III) while others may be excitatory
(group I) (Schoepp, 2001). Additional glutamatergic factors that may be involved
in regulating resting extracellular Glu levels are iGluRs, Glu transporters, and the
cystine-Glu exchanger, all of which are commonly present at glutamatergic
synapses.
This study was aimed at determining resting Glu levels and the factors
that influence these levels in the brain of awake behaving rats. In these studies,
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we examined the differences in resting Glu in the striatum and PFC of two
different rat strains, Fischer 344 and Long Evans rats.

Additionally, we

determined the effect of anesthesia on resting Glu levels and made direct
comparisons between resting Glu in the striatum and PFC of the awake and
anesthetized rats using an amperometric recording technique.

We also

examined the influences of TTX, a sodium channel blocker, mGluR group II
agonist and antagonist, and a cystine-Glu exchanger blocker on resting Glu
levels.
Methods
Animals were housed in the conditions described in Chapter Two. Male
Fischer 344 and Long Evans rats were between three and six months of age at
the time of implantation surgery. Surgical procedures, MEA implantation in the
striatum and PFC, and recording procedures followed those outlined in Chapter
Two. Briefly, male Fischer 344 and Long Evans rats were implanted either in the
striatum or PFC under isoflurane anesthesia and allowed to recover for two days
prior to recording sessions. On recording days, rats were allowed approximately
ten minutes to acclimate to the recording chamber prior to establishing a
connection between the implanted MEA and the FAST-16 recording system.
Once a connection was established and recordings started, a sampling rate of 1
Hz was maintained throughout the recording session.

After recording for

approximately 30 minutes, or longer if needed, and baseline was established, a
15 second interval was used to determine resting Glu levels.

Recordings

continued for other experimental use, such as, local application of Glu. Data
analysis involved an ANOVA with a Tukey’s post hoc test. Significance was
determined at p<0.05.
Results
Resting Glu levels in awake rats were measured in the striatum and PFC
of Fischer 344 and Long Evans rats using the self-referencing technique
described above. Briefly, the self-referencing site currents were subtracted from
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the Glu recording site currents during unstimulated recordings (Figure 3.1). We
observed a highly significant difference in resting levels of Glu in the PFC (37.4 ±
3.0 µM Glu; n=7) of Long Evans rats compared to resting measures in the
striatum (5.8 ± 0.4 µM Glu; n=7) of Long Evans rats and measures in the striatum
(10.4 ± 0.7 µM Glu; n=3) and PFC (9.8 ± 0.7 µM Glu; n=7) of Fischer 344 rats
(Figure 3.2). No other significance difference was observed in resting Glu levels
in the striatum and PFC in the Fischer 344 and Long Evans rats. A comparison
with microdialysis in the awake rat on resting Glu levels in the striatum and PFC
is shown in Table 3.1.
After verifying that our MEA recording system was able to reliably
measure Glu in chronically implanted and behaving rats over multiple days
(Figure 3.3), we wanted to determine the effects of anesthesia, specifically
urethane, on resting Glu levels in the brain. After verifying that the MEA was
functioning properly by locally applying Glu (see Chapter 4), the rats were
administered urethane (1.25 mg/kg, i.p.) as per our usual protocols for
anesthetizing rats in our laboratory for acute in vivo amperometry measures (Day
et al., 2006; Nickell et al., 2005). In this study, the resting Glu levels significantly
decreased by an average of 58% (resting measures of 35.3 ± 2.5 µM dropped to
14.9 ± 3.1 µM; n=4; p<.001) in the 2.5 hours following the initial urethane
injection (Figure 3.4). Additionally, resting Glu levels in anesthetized Fischer 344
rat striatum (1.4 ± 0.2 µM) and frontal cortex (1.6 ± 0.3 µM) were significantly
decreased compared to resting Glu levels in the awake Fischer 344 rat striatum
and

PFC

(Figure

3.5)

as

measured

by

enzyme-based

amperometry

(anesthetized data taken from Day et al., 2006).
The effect of TTX was studied in the PFC of awake male Long Evans rats.
TTX was determined to decrease resting Glu levels in the PFC of Long Evans
rats on average approximately 25 % (Figure 3.6).

However, TTX did not

completely diminish the resting Glu levels, as was observed in recordings in the
anesthetized rat (Day et al., 2006). These results showed that resting Glu levels
in the PFC of awake Long Evans rats were at least partially neuronally derived.
However, the resting Glu levels must also have other contributing components.
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For

this

reason,

we

wanted

to

determine

the

effects

of

(S)-4-

carboxyphenylglycine (CPG) on resting Glu levels. CPG has been reported to be
a cystine-Glu exchanger blocker (Baker et al., 2002; Melendez et al., 2005) as
well as a competitive group I mGluR antagonist/weak group II mGluR agonist
(Tocris Bioscience, Ellisville, MO). This would suggest that when locally applying
CPG, there should be an observed decrease in resting Glu levels. However,
upon local application of CPG in the PFC of awake Long Evans rats, we
observed a rapid, robust increase in Glu with the spike lasting approximately 2
minutes, followed by a prolonged slight decrease in Glu levels, lasting
approximately 15 minutes (Figure 3.7). Additionally, group II mGluR agonist and
antagonist were examined for their effect on resting Glu levels. The agonist
(LY379268) decreased resting Glu levels 3.0 ± 0.4 µM below basal levels while
the antagonist (LY341495) increased resting Glu levels 13.8 ± 4.7 µM above
basal levels (Figures 3.8 and 3.9).
Discussion
The current self-referencing recording techniques with MEAs can be used
to effectively and reliably measure resting (tonic) Glu levels. Our data show that
there was a significant difference in resting Glu levels between the striatum and
PFC in Long Evans rats as well as between the PFC of Ficher 344 and Long
Evans rats. Direct comparisons to previous studies performed in our laboratory
using the same method for detecting Glu have reported that the resting Glu
levels in the frontal cortex of the anesthetized Fischer 344 rats were 1.6 ± 0.3 µM
and in the striatum they were 1.4 ± 0.2 µM (Day, et al., 2006), or on average
approximately 84% to 87% decreased compared to our freely moving Fischer
344 recordings.

The differences observed in resting Glu between the

anesthetized and awake rat were not surprising.

Studies using microdialysis

report resting Glu in the anesthetized rat striatum to be approximately 1.3 – 2.7
µM when sampling 20-24 seconds, which is comparable to our value of 1.4 µM
(Cellar, et al., 2005).

However, in an awake rat model using microdialysis

measures in the striatum, resting Glu levels were reported to be 0.202-0.82 µM
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when sampling every 15-20 minutes (Di Cara et al., 2001; Segovia et al., 2001).
Additionally, 10 to 20 minute microdialysis measures of resting Glu in the frontal
cortex of the awake rat ranged between ~2 µM and ~9 µM (Baotell et al., 1995;
Rocha et al., 1996; Table 3.1). Resting Glu discrepancies using microdialysis
may be explained by the sampling time and method, the extent of damage, and
the origin of the Glu pool being sampled. In addition, our faster sampling rates
coupled with decreased tissue damage may have contributed to the observed
higher resting Glu levels in the awake rat. Westerink’s group (Oldenziel et al.,
2006a) has also reported an elevated resting Glu levels (18.2 ± 9.3 µM) in the
striatum

of

anesthetized

rats

using

an

enzyme-based

microsensor with an osmium-containing redox polymer.

hydrogel-coated

However, previous

studies using redox hydrogel-coated enzyme-based Glu biosensors were limited
by their response time of 8-10 seconds (Belay et al., 1998; Oldenziel et al.,
2006a; Oldenziel et al., 2006b).
There was no significant difference observed in resting Glu levels between
the striatum and PFC of Fischer 344 rats. This finding was similar to the lack of
significant difference seen by Day et al. (2006) between the striatum and frontal
cortex in anesthetized Fischer 344 rats. However, there remains an 84-87%
increase observed in the current awake Fischer 344 striatum and PFC studies
compared to those observed in the anesthetized Fisher 344 rats by Day et al.
(2006). The biggest contributor to the increased resting Glu levels in the awake
animal model is most likely due to the system being relieved from the
suppressive effects caused by anesthesia.
We hypothesized that observed differences in resting levels of Glu
between the awake and anesthetized animals using our enzyme-based MEAs
were largely due to an effect of the anesthetic (urethane) on resting Glu levels.
We tested the effects of urethane on resting Glu by administering urethane to
freely behaving rats using the same protocols used in anesthetized studies. Our
freely moving studies in the PFC showed a 58% decrease in resting Glu levels
following urethane dosing. The point at which there is a 58% decrease in Glu
levels was the time point at which surgery would begin for typical anesthetized
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recordings. However, typical anesthetized recordings in our studies would occur
following approximately 0.5-3 hours additional time allowing for a deeper plane of
surgical anesthesia.

These data show that anesthetics affected resting Glu

levels in the rat brain and contributed to the previous poor estimates of resting
Glu levels.
In anesthetized animals, TTX diminished resting Glu by approximately
100% (Day et al., 2006), whereas in the awake animals, TTX decreased resting
Glu by approximately 25%. The current data supplemented with work in the
anesthetized animal by Day et al (2006) suggests that, while both the
anesthetized and awake animal models exhibit resting Glu levels that are at least
in part sodium channel-dependent as shown by the TTX data, anesthesia may
block or inhibit other pools of Glu that contribute to resting levels resulting in
diminished resting Glu. Additionally, the awake rat may have the capability to
better clear TTX from the extracellular space compared to the anesthetized rat.
Since, in the awake rat model, urethane anesthesia was observed to
decrease resting Glu levels by 58% and TTX decreased resting levels 25% in the
PFC, there must still be other contributors to resting Glu.

One possible

mechanism contributing to resting Glu levels could be group II mGluR, which act
as inhibitory autoreceptors. This suggested that a mGluR group II agonist acting
presynaptically would actually have an inhibitory effect on Glu release into the
synaptic cleft. The mGluR group II agonist (LY379268) was shown to decrease
resting Glu levels by approximately 8 % in the PFC of Long Evans rats,
supporting the idea that there may still be other mechanisms affecting
extracellular Glu levels.
Another mechanism proposed to regulate resting Glu levels was the
cystine-Glu exchanger (Baker et al., 2002; Melendez et al., 2005).

This

exchanger is located on glial cells and acts via uptake of cystine into the glia cells
coupled with the release of Glu into the extracellular space. CPG is thought to
act by blocking the cystine-Glu exchanger. As such, a decrease in extracellular
Glu would be expected when CPG was applied. Additionally, Tocris Bioscience
reported CPG as a mGluR group I competitive antagonist and a weak mGluR
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group II agonist, which when acting presynaptically on Glutamatergic neurons
should induce a decrease in extracellular Glu.
unexpected initial increase in Glu.

However, we observed an

The increase peaked within seconds at

approximately 20 µM above resting Glu levels and the entire duration lasted
approximately two minutes, and therefore, may not have been detected, or the
response may have been muted, in previous microdialysis studies.

One

explanation for the increase in Glu may be because the group II mGluR also
resides on GABAergic neurons, and act to inhibit GABA release. If this inhibitory
action on GABA was increased via an mGluR group II agonist, it could lead to a
decrease on the GABAergic inhibition on glutamatergic neurons. Following the
initial increase in Glu there was a prolonged decrease that averaged
approximately 4 µM below resting Glu levels and lasted approximately 15
minutes which was most likely the decrease observed in previous microdialysis
studies. A summary of the approximate decreases observed in resting Glu levels
due to urethane, TTX, CPG and LY379268 can be seen in Table 3.2.
Taken together, the data show that while resting Glu levels remained
consistent over multiple days within a given brain region, there were differences
between brain regions as well as rat strains. We also determined that the Glu
pool sampled using our technique is at least partially neuronally derived and that
there are many factors located throughout the synapse that may influence Glu
levels, including mGluRs and the cystine-Glu exchanger.

Furthermore, our

results show that resting Glu levels were significantly decreased by the
anesthetic urethane, promoting a need for studies in the awake, freely behaving
animal model to have a more accurate knowledge about neurotransmitter
function.
Copyright © Erin Cathleen Rutherford
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Frontal Cortex

Striatum

Table 3.1: Resting L-Glutamate Levels in Awake Rats as Measured with Microdialysis or
Enzyme-Based Amperometry
Resting Glu Concentration

Technique

Rat Strain

Citation

0.274 ± 0.072 µM

microdialysis

Wistar

Di Cara et al., 2001
J. Neurochem.

0.64 ± 0.18 µM

microdialysis

Wistar

Segovia et al., 2001
Neurochem. Res.

10.4 ± 0.7 µM

enzyme-based
amperometry

Fischer 344

Rutherford et al.
manuscript in preparation

5.8 ± 0.4 µM

enzyme-based
amperometry

Long Evans

Rutherford et al.
manuscript in preparation

~8 µM

microdialysis

Wistar

Rocha et al., 1996
Epilepsy Res.

~2 µM

microdialysis

SpragueDawley

Boatell et al., 1995
J. Neurochem.

9.8 ± 0.7 µM

enzyme-based
amperometry

Fischer 344

Rutherford et al.
manuscript in preparation

37.4 ± 3.0 µM

enzyme-based
amperometry

Long Evans

Rutherford et al.
manuscript in preparation
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Table 3.2: Effects of Application of Urethane, TTX, CPG or LY379268 on Resting LGlutamate Levels

Substance Tested

Decrease from Resting Glu (%)

Urethane

~58

TTX

~25

CPG

~11

LY379268

~8
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Figure 3.1: Determination of Resting L-Glutamate Levels
Representative tracing of GluOx coated recording site (red) and sentinel, or self-referencing site
(black). The difference between the GluOx and sentinel baselines is an indication of resting
(basal) Glu. Glu (5 mM, 1 µL) was locally applied (indicated by arrow) and detected using a selfreferencing MEA. Taken from Rutherford et al., 2007.
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Figure 3.2: Resting L-Glutamate Levels in the Striatum and Prefrontal Cortex of Fischer
344 and Long Evans Rats
Resting Glu levels were measured in the striatum and PFC of Fischer 344 and Long Evans rats.
The striatum of Long Evans rats and the striatum and PFC of Fischer 344 rats were significant
compared to the PFC of Long Evans rats (***p<0.001).
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Figure 3.3: Resting L-Glutamate Levels in the Prefrontal Cortex of Awake Long Evans Rats
Resting Glu levels were recorded on days 3, 5, and 7 post-implantation in the PFC of freely
behaving Long Evans rats using the self-referencing recording technique (n=7). Resting Glu
levels were consistent up to one week post-implantation.
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Figure 3.4: Effects of Urethane on Resting L-Glutamate Levels in the Prefrontal Cortex of
Long Evans Rats
Resting Glu levels were continuously measured in the PFC of Long Evans rats. Rats were
anesthetized during recordings with urethane (3 i.p. injections, 25 minutes apart, 1.25 g/kg total).
Resting Glu levels decreased 58% over 2.5 hours (n=4; *p<0.05; **p<0.01; ***p<0.001). Taken
from Rutherford et al. 2007.
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Figure 3.5: Resting L-Glutamate Levels as Measured by Enzyme-Based Microelectrode
Arrays in Fischer 344 Rats
Resting Glu levels in the striatum and PFC of awake (red) and anesthetized (blue) Fischer 344
rats using the same enzyme-based self-referencing MEA recording technique (***p<0.001 vs. Str
Awake; ###p<0.001 vs. PFC Awake). Anesthetized data was taken from Day et al., 2006.
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Figure 3.6: Effects of Tetrodotoxin on Resting L-Glutamate Levels in the Prefrontal Cortex
of Long Evans Rats
Resting Glu levels were continuously measured in the PFC of Long Evans rats. TTX (100 µM, 3
µL) was locally applied (indicated by arrow). Resting Glu levels decreased ~ 25% as indicated by
the inset (n=4; *p<0.05).
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Figure 3.7: Effects of (S)-4-Carboxyphenylglycine on L-Glutamate in the Prefrontal Cortex
of Long Evans Rats
Glu levels were altered due to local application of CPG (50 µM, 3 µL). There was an initial rapid
increase in Glu followed by a prolonged decrease in Glu. The increase in Glu was significantly
elevated over resting Glu levels (~12 µM; n=4; *p<0.05).
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Figure 3.8: Typical Changes in L-Glutamate with Local Application of a mGluR Agonist and
Antagonist in the Prefrontal Cortex of Long Evans Rats
Representative tracings of resting Glu levels continuously recorded in the PFC of Long Evans
rats. mGluR agonist (LY379268) and antagonist (LY341495) were locally applied (100 µM, 3 µL,
as indicated by arrows).
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Figure 3.9: Effects of mGluR Agonist and Antagonist on L-Glutamate Levels in the
Prefrontal Cortex of Long Evans Rats
mGluR2/3 agonist (LY379268) and antagonist (LY341495) were locally applied (100 µM, 3 µL).
Resting Glu levels were altered due to local applications of mGluR2/3 agonist and antagonist. The
agonist decreased resting Glu levels by ~2 µM, while the antagonist increased resting Glu levels
~12 µM (n=4; **p<0.01 vs. resting Glu levels).
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Chapter Four: Do Measures of Exogenous Glutamate Change Over Time,
Between Brain Regions, and Between Rat Strains in Awake Rats?
Introduction
Many similarities exist between rat strains as to their basic neuronal
circuitry. The PFC is thought to be involved in executive functions, such as
cognition, and the striatum is involved with motor function in both the Fischer 344
and the Long Evans rats. However, there are also many difference between rat
strains. The Fischer 344 rat has been used primarily in age-related studies,
while the Long Evans rat is used primarily in behavior-related studies. Another
major difference between the strains is the Fischer 344 rat is inbred and albino,
while the Long Evans rat is outbred and pigmented.
The neuronal circuitry and cell density is known to vary between brain
regions, however, little work has been done to establish the effects of these
differences on extracellular Glu clearance between brain regions and rat strains.
Glu clearance can be affected by many things, including the density of Glu
transporters present in a given brain area, the effectiveness of the transporters,
and the regional cell density (Segovia et al., 2001b). Additionally, Glu uptake in
the striatum has been shown to significantly decrease in aged rats compared to
young adult rats (Nickell et al., 2006). One way to evaluate Glu clearance is
through local applications of exogenous Glu. This allows for clearance to be
studied independent of Glu release. While studying the effects of exogenous Glu
alone can not give definitive answers as to the cause of differences in Glu
clearance between brain regions, it can give some insight into the differences
that may exist and the changes that may occur over time.
In the present study we examine the differences between extracellular Glu
levels measured in the striatum and PFC of Fischer 344 and Long Evans rats
due to the local application of 1 µL of 5 mM Glu. Differences in these levels may
be an indication of differences in clearance. To examine this, t80 was determined
for both brain regions in both rat strains.
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Although t80 cannot definitively

determine the cause of the potential differences observed, it can be used to
determine differences in Glu clearance kinetics.
Methods
Animals were housed in the conditions described in Chapter Two. Male
Fischer 344 and Long Evans rats were between three and six months at the time
of implantation surgery. Surgical procedures, MEA implantation in the striatum
and PFC, and recording procedures followed those outlined in Chapter Two.
Briefly, male Fischer 344 and Long Evans rats were implanted either in the
striatum or PFC under isoflurane anesthesia and allowed to recover for two days
prior to recording sessions. On recording days, 3, 5, and 7 post-implantation,
rats were allowed approximately ten minutes to acclimate to the recording
chamber prior to establishing a connection between the implanted MEA and the
FAST-16 recording system. Once a connection was established and recordings
started, a sampling rate of 1 Hz was maintained throughout the recording
session. After recording for approximately 30 minutes, or longer if needed, and
baseline was established, a 33-guage internal cannula attached with connecting
tubing to a 10 µL Hamilton syringe and filled with 5 mM Glu (isotonic; pH 7.2-7.4)
was inserted into the guide cannula aimed among the four Pt recording sites on
the implanted MEA.

A series of four, 1 µL ejections of 5 mM Glu were

performed, allowing time between each one for baseline to be re-established.
Data analysis involved an ANOVA with a Tukey’s post hoc test. Significance was
determined at p<0.05.
Results
The FAST-16 recording system allowed for reliable second-by-second
recordings of Glu in the striatum and PFC of awake, freely behaving rats. We
were able to consistently implant the MEA assemblies and record Glu for as long
as 3 weeks, reliable for 7 days, in the awake rats. Glu recordings were verified in
vivo by locally applying a Glu solution (5 mM isotonic, pH 7.4, 1 µL) with the use
of the cannula directed among the 4 recording sites approximately 100 µm from
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the microelectrode surface. The Glu peaks produced by local application were
robust and reproducible as can be seen in the representative tracing of the selfreference subtracted local applications of Glu in the striatum of a Long Evans rat
(Figure 4.1). This measure was repeatable within animals, between animals, and
over multiple days. This self-referencing subtracting technique (Burmeister and
Gerhardt, 2001) was also used to measure resting Glu levels as discussed in
Chapter Three.
Another method for verifying Glu signals in vivo was performed by locally
applying Glu (1 µL) while recording at applied potentials of either +0.7 V or +0.2
V versus an Ag/AgCl reference electrode. A sharp, robust peak was observed
with locally applied Glu recorded at +0.7 V vs. Ag/AgCl. However, when Glu was
applied while the microelectrodes were polarized at +0.2 V vs. Ag/AgCl, little to
no change in signal was observed (n=4) (Figure 4.2). Our prior studies have
shown that H2O2 is oxidized primarily at +0.7 V vs. Ag/AgCl at the Pt recording
sites (Pomerleau et al., 2004). Thus, this approach demonstrated that the in vivo
signal derived from Glu is converted to H2O2 by the enzyme layer.
Based on the verification studies, we were assured that we were
measuring Glu in the awake rat brain.

The self-referencing technique was

employed throughout these studies used both to verify that we were measuring
Glu and to ensure that our maximum amplitudes reported were produced by Glu.
Locally applied Glu measures were studied in the striatum and PFC of Fischer
344 and Long Evans rats. Measured responses in the PFC of Long Evans rats
were not significantly different over days 3, 5, and 7 days post-implantation
(Figure 4.3).

However, responses observed in the PFC were significantly

increased compared to the striatum within rat strains (Long Evans striatum: 17.3
± 3.5 µM; Long Evans PFC: 53.0 ± 6.8 µM; Fischer 344 striatum: 8.7 ± 1.3 µM;
Fischer 344 PFC: 26.9 ± 3.2 µM) (Figure 4.4). Additionally, the PFC in Long
Evans rats was significantly increased compared to the PFC in Fischer 344 rats.
We were interested in Glu clearance in the brain and if it changed over
time.

When locally applying exogenous Glu on days 3, 5, and 7 post-

implantation, we determined the time it took for 80% of the signal to decay, or t80.
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There was no significant difference in t80 over days; however, we did observe a
trend in increased t80 as the duration of the implant increased in the PFC of
Fischer 344 rats (Day 3: 33.4 ± 12.4 seconds; Day 5: 42.1 ± 16.4 seconds; Day
7: 72.7 ± 5.3 seconds) (Figure 4.5). Additionally, there was a decreasing trend
observed in the PFC of Long Evans rats (Day 3: 8.5 ± 3.5 seconds; Day 5: 6.1 ±
0.8 seconds; Day 7: 5.5 ± 1.8 seconds) (Figure 4.6). Because the maximum
amplitudes from local application of 5 mM Glu were not significantly different in
the striatum of Fischer 344 and Long Evans rats, we were able to make a direct
comparison of Glu clearance in these animals. The t80 in the striatum (6.8 ± 0.3
seconds) of Fischer 344 rats was significantly faster compared to the striatum
(18.2 ± 3.0 seconds) of Long Evans rats (Figure 4.7).

Additionally, a Glu

clearance comparison was made between amplitude matched recordings from
the striatum of anesthetized (5.9 ± 0.8 seconds) and awake Fischer 344 rats
(anesthetized data is unpublished data from Dr. Justin Nickell). There was no
significant difference in t80 in the striatum of anesthetized rats compared to
awake rats (Figure 4.8).
Discussion
This study demonstrates that chronic enzyme-based MEA recordings in
the awake freely moving rat offers a robust method for monitoring Glu in vivo with
minimal tissue damage at the site of implant. Current microdialysis methods are
limited in reliable temporal resolution (minutes) and are only capable of recording
over a single day per animal in the anesthetized or unanesthetized rat models
(Shou et al., 2004). In our studies, we extend this recording capacity to one
week, routinely.
Locally applied Glu recordings in the striatum and PFC of Fischer 344 and
Long Evans rats were reproducible in maximum amplitude from day 3 through
day 7 post implant. Signals due to locally applied Glu were also measured in the
striatum of unanesthetized Long Evans rats. In the striatum, Glu signals were
reproducible through day 7, as in the PFC. However, the average maximum
amplitudes of the Glu signals were smaller compared to the PFC, supporting
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potential differential regulation of Glu in the rat PFC vs. rat striatum in the Long
Evans rat.
When using in vivo amperometry, identifying the molecule of interest is
frequently questioned. First the ability of the enzyme-based MEA to differentially
record for a specific molecule, in this case Glu was due to the high selectivity of
the enzyme (GluOx) for its substrate (Glu). Another way we addressed this issue
was by varying the applied potential of the recordings. The reporter molecule,
H2O2, resulting from the enzymatic breakdown of Glu by GluOx was oxidizable
predominately at +0.7 V vs. a Ag/AgCl reference electrode. However, as we
have shown, when one drops the applied potential to +0.2 V vs. a Ag/AgCl
reference electrode, we lost the Glu signal because H2O2 was no longer oxidized
at the surface of the MEA. To further support the ability of our enzyme-based
MEA to detect Glu, we included an important and unique feature of our MEAs;
the simultaneous self-referencing of the measured signal. By subtracting the
signals obtained on the 2 adjacent sites (sentinel sites) that were not coated with
GluOx from the signals obtained from the sites that measure Glu, we were able
to ascertain that the resulting signal was derived from Glu.

All possible

interferents being detected by the Pt sites and/or noise were subtracted out of
the signal.

Thus self-referencing methods were employed throughout this study

to ensure that resting levels and peak responses (maximum amplitude) were due
primarily to changes in extracellular Glu levels.
Additionally, we determined the time it took for 80% of the signal to
decrease in the PFC of Fischer 344 rats on days 3, 5, and 7 post-implantation.
Signals were amplitude matched within brain regions and rat strains and t80s
were examined. There was no significant difference in t80 over days in the PFC
of Fischer 344 or Long Evans rats. However, there was a trend observed in
Fischer 344 rats with day 3 having the fastest t80 and day 7 having the slowest.
These results show a trend in slower clearance over time which may suggest
fewer glia surrounding the implantation site or an decrease in the number of
transporters located on the glia. However, a decreasing trend was observed in
the PFC of Long Evans rats with day 7 having the fastest t80. These results show
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a trend in faster clearance over time which may be due to an increase in glia
surrounding the implantation site or an increase in the number of transporters
located on the glia. Additionally, although a direct comparison cannot be made
since the maximum amplitudes with volume matched local applications of Glu
were significantly increased in the PFC of Long Evans rats compared to Fischer
344 rats, the t80 values for the PFC of Fischer 344 rats were approximately 4-13
fold increased compared to the Long Evans rats. This seems counterintuitive.
One would expect slower t80s to be associated with larger amplitudes.
Additionally, amplitude matched samples were used to make a direct comparison
in Glu clearance in the striatum of Long Evans and Fischer 344 rats.

Glu

clearance was significantly faster in the in the striatum of Fischer 344 rats
compared to Long Evans rats. Taken together, these results suggest that there
may be a difference in regulation of brain morphology and transporters between
the two rat strains and that there may be further differentiation between the brain
regions in the different rat strains. However, when comparing Glu clearance in
the striatum of Fischer 344 rats between awake and anesthetized rats, there was
no significant difference. These results suggest that while there are differences
in Glu clearance that exist between rat strains and brain regions and the
anesthetic urethane decreased resting Glu (Chapter Three), the urethane does
not act on Glu levels through Glu clearance mechanisms.
Copyright © Erin Cathleen Rutherford
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Figure 4.1: Representative Tracing of Local Application of 5 mM L-Glutamate (1 µL) in the
Striatum of a Long Evans Rat
Representative tracing of locally applied Glu (5 mM, 1 µL) in the striatum of Long Evans rats. Glu
was locally applied (indicated by arrows) and detected using a self-referencing MEA. Tracing
shown is the result of subtracting the self-referencing site from the GluOx coated site. Glu peaks
were rapid, robust, and reproducible.
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Figure 4.2 Local Application of L-Glutamate at +0.7 V and +0.2 V vs. Ag/AgCl Reference
Electrode
Glu (5 mM, 1 µL) was locally applied (indicated by arrows) with either +0.7 V or +0.2 V vs. a
Ag/AgCl reference electrode. At +0.7 V an increase in current (Glu) was observed. However, at
+0.2 V no signal was observed, indicating that we are measuring Glu at +0.7 V vs. a Ag/AgCl
reference electrode. Taken from Rutherford et al., 2007.
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Figure 4.3: Local Application of 5 mM L-glutamate (1 µL) Days 3, 5, and 7 Post-Implantation
in the Right Prefrontal Cortex of Long Evans Rats
Glu (5 mM, 1 µL) was locally applied over days in the PFC of Long Evans rats. There was no
significant difference observed (n=7). Taken from Rutherford et al., 2007.
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Figure 4.4: Local Application of 5 mM L-glutamate (1 µL) Day 3 Post-Implantation in the
Striatum and PFC of Fischer 344 and Long Evans Rats
Glu (5 mM, 1 µL) was locally applied on day 3 post-implantation in the striatum (Str) and PFC of
Fischer 344 (F344) and Long Evans (LE) rats. Levels in the PFC of Long Evans rats were
significantly increased as compared to the striatum of Long Evans rats and the PFC of Fischer
344 rats. The PFC of Fischer 344 rats was also significantly increased compared to the striatum
of Fischer 344 rats (n=7 except Str F344 n=4; *p<0.05; **p<0.01).

63

80
70

Seconds

60
50
40
30
20
10
0
Day 3

Day 5

Day 7

Figure 4.5: t80 on Days 3, 5, and 7 Post-Implantation in the Prefrontal Cortex of Fischer 344
Rats
t80s over days following local application of Glu (5 mM, 1 µL) were calculated and analyzed in the
PFC of Fischer 344 rats. No significance was observed between t80 over days 3, 5, and 7 postimplantation. However, a trend was observed in elongated t80 duration associated with longer
implant durations (n=7).
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Figure 4.6: t80 on Days 3, 5, and 7 Post-Implantation in the Prefrontal Cortex of Long Evans
Rats
t80s over days following local application of Glu (5 mM, 1 µL) were calculated and analyzed in the
PFC of Long Evans rats. No significance was observed between t80 over days 3, 5, and 7 postimplantation (n=7).
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Figure 4.7: t80 in the Striatum of Long Evans and Fischer 344 Rats
t80s in the striatum of Long Evans and Fischer 344 rats following local application of Glu (5 mM, 1
µL, amplitude matched) were calculated and analyzed. t80 in the striatum of Long Evans rats
were significantly longer than those observed in the striatum of Fischer 344 rats (n=7 (LE); n=4
(F344); *p<0.05).
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Figure 4.8: t80 in the Striatum of Awake and Anesthetized Fischer 344 Rats
t80s in the striatum of awake and anesthetized Fischer 344 rats following local application of Glu
(5 mM, amplitude matched) using the same enzyme-based self-referencing MEAs were
calculated and analyzed. There was no difference in Glu clearance (t80) in the striatum of awake
and anesthetized Fischer 344 rat striatum (n=4 (awake); n=5 (anesthetized)). Anesthetized data
is unpublished data from Dr. Justin Nickell.
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Chapter Five: The Extent of Damage on Surrounding Tissue due to Chronic
Implantation of the Microelectrode Array
Introduction
Many devices have been established to study Glu in the mammalian CNS
including patch-clamp methods, carbon fiber microelectrodes, hydrogel-coated
microsensors, and microdialysis probes. The ideal technique for measuring Glu
in vivo is one that is minimally invasive, has the capability to chronically record
Glu with low levels of detection and a high temporal resolution, and can record
resting Glu levels. These methodologies can address several of these issues,
however, none can address all by themselves.

Patch-clamp methods allow

membrane potentials associated with Glu to be measured in single cells,
however, it is limited in its ability to be used in the whole animal over several
days. Carbon fiber microelectrodes are minimally invasive and can be used in
the awake animal, but it is hard to determine true resting Glu levels since there is
only one recording channel and therefore no sentinel electrode. Microdialysis
methods allow for low levels of detection, but produce damage up to 1.4 mm
remote from the implant site and have slow response times (Tucci et al., 1997;
Clapp-Lilly et al., 1999; Belay et al., 1998; Kennedy et al., 2002; Borland et al.,
2005).
To address the need for a single technique with the capabilities to
chronically record Glu in the CNS of awake animals with low limits of detection,
high temporal resolution and the ability to record resting Glu levels, our
laboratory has developed an enzyme-based multisite ceramic MEA that is light
weight and has been used to routinely record in anesthetized animals (Nickell et
al., 2005; Day et al., 2006). This technology has been successfully translated
into chronic use in the freely moving animal (Pomerleau et al., 2003; Hascup et
al., 2006; Rutherford et al., 2007) with Glu recordings possible through day 23
post-implantation and routinely through day 7 post-implantation without
significant loss of sensitivity for Glu.

Additionally, successful H2O2 test have

been performed in vivo through day 90 post-implantation, suggesting that as we
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improve upon our coating procedure we will be able to extend the duration that
we are able to reliably record Glu.
As we extend the possible recording lifespan of our MEAs, it is important
to establish the effects of chronic implantation on surrounding tissue. While the
ceramic MEA tip is small and minimally invasive, the issue of tissue damage
associated with chronic implantation of our ceramic MEAs has not been studied.
These experiments were designed to address this issue. In this study, Long
Evans rats were chronically implanted in the right PFC for either 1 or 3 days, 1, 2,
4, 8, 16, or 24 weeks. Following this time, animals were sacrificed and the
brains were sectioned and stained for GFAP and Iba1 to determine changes in
astrocytes and microglia levels surrounding the MEA implant site.
Methods
Animals were housed in the conditions described in Chapter Two. Long
Evans rats were between three and six months at the time of implantation
surgery.

Surgical

procedures,

MEA

implantation

in

the

PFC,

and

histopathological studies followed those outlined in Chapter Two. Briefly, male
Long Evans rats were implanted in the PFC under isoflurane anesthesia and
allowed to recover. Following implantation surgery, rats were returned to the
animal facilities and remained there for either 1 or 3 days, 1, 2, 4, 8, 16, or 24
weeks. At these time points, rats were briefly anesthetized with isoflurane and
transcardially perfused with 4% paraformaldehyde. Brains were extracted and
stored in 4% paraformaldehyde for three days. After three days, the storage
solution was changed to 0.1 M phosphate buffer with 10% sucrose. Brains were
then sliced and stained with a marker for astrocytes (GFAP) or a marker for
microglia (Iba1) (courtesy of Dr. Ingrid Strömberg at Umeå University, Sweden).
Pedestal MEAs did not have an attached guide cannula and were coated with
Nafion® only, no GluOx. There were no recording sessions with these animals.
Data analysis involved an ANOVA with a Tukey’s post hoc test. Significance was
determined at p<0.05.
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Results
MEAs were chronically implanted in to the right PFC of Long Evans rats.
Following 1 or 3 days, 1, 2, 4, 8, 16, or 24 weeks rats were sacrificed and their
brains were extracted and sectioned. MEA placement in the PFC was verified
with cresyl violet staining (Figure 5.1).

Brain sections were analyzed to

determine the extent of damage on tissue surrounding the MEA implantation site
by staining with Iba1 (microglia) and GFAP (astrocytes). Mean densities for Iba1
and GFAP were reported. The shapes of the microglia were also examined to
determine activation status.
GFAP staining was used to visualize astrocyte composition in the PFC of
chronically implanted rats. GFAP mean density surrounding the implant site was
elevated at 3 days, 1, 2, 4, and 8 weeks compared to 1 day implants (3.83 ± 1.64
mean density), however, a significant difference was only observed at 16 (39.47
± 7.25 mean density) and 24 (33.60 ± 7.16 mean density) weeks postimplantation (Figure 5.2). Additionally, elevated GFAP staining was confined to
within 50-100 µm surrounding the implantation site, regardless of the duration of
the implant (Figure 5.3). However, glial scaring was observed at the implant site
in the 6 month implants (Figure 5.4).
Iba1 staining was used to visualize microglia composition in the PFC of
chronically implanted Long Evans rats (Figure 5.6, left). As seen with the GFAP
staining, increased Iba1 staining was limited to within 50-100 µm of the
implantation site. The levels observed did not reach an astrocyte density that
would be associated with an injury.

There was a dramatic increase in Iba1

staining observed in the contralateral hemisphere of an eight week implant where
a skull screw came into contact with the brain (Figure 5.6, right).

In rats

implanted for 1 week (29.67 ± 5.50 mean density), there was a significant
difference in Iba1 staining as compared to control hemispheres (10.30 ± 0.55
mean density) and 1 day implants (9.32 ± 2.38 mean density). However, the
difference in Iba1 levels compared to control levels and 1 day implants returned
to normal levels by 24 weeks (15.08 ± 3.86 mean density) with the implant
(Figure 5.5). Additionally, when analyzing the individual microglia cell type, there
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were very few rounded, or activated, cells, supporting that our ceramic MEAs are
well tolerated by the rat brain (Figure 5.4) (Laurenzi et al., 2002).
Discussion
We investigated the histopathological effects from chronic MEA
implantation. The implantation durations of 1 and 3 days yielded similar findings
for GFAP (astrocytes) and Iba1 (microglia) staining. At close evaluation, both
GFAP and Iba1 staining were seen to surround the MEA tracts, extending into
tissue on average by 50 – 100 µm. No further increase in staining was seen in
adjacent areas to the MEA tracts. There was a slight elevation observed in
number of astrocytes immediately surrounding the site of implant that increased
as the implant duration increased. However, this elevation was not significant
until 16 weeks with the implantation and did not extend more than 50-100 µm into
the surrounding tissue.

These data correlate with Glu Clearance (t80) data

(Chapter Four) obtained from the PFC of Long Evans rats on days 3 and 7 postimplantation. As the relative staining for astrocytes (the majority of high affinity
Glu transporters are located on astrocytes – See Chapter One) increases, Glu is
cleared more rapidly. Furthermore the number of microglia was only significantly
increased at 1 week (29.67 ± 5.50 mean density) post-implantation compared to
control hemispheres (10.30 ± 0.55 mean density) and to 1 day (9.32 ± 2.38 mean
density) implantations.

However, Iba1 levels returned to normal by 24 week

implantations. Figure 5.6 is an example of the microglia observed at the site of
implantation and the degree of microglia activation that would be observed in an
injury. This was produced by a skull screw that was placed too deep and came
into contact with the tissue. Additionally, freely moving microdialysis studies yield
a high degree of damage to the brain at the site of implant with extended damage
observed up to 1.4 mm from the site of implantation within 30 hours (Clapp-Lilly
et al., 1999; Borland et al., 2005). By contrast, our MEAs did not disrupt brain
tissue more than 50-100 µm from the microelectrode tracts and cell morphology
remained healthy with normal processes and cell shape up to 24 weeks postimplantation.
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Additionally, pedestal MEA implants were cable of measuring H2O2 for up
to 90 days in the awake, freely moving rat with no apparent adverse effects to the
rat.

This suggests that as we improve upon our enzyme-based technology,

through cross-linking and coating procedures, we will be able to increase the
number of consecutive days we can record Glu in the unanesthetized animal.
Furthermore, our H2O2 data support that the loss of ability to record Glu is due to
an enzyme coating related function, not due to loss of MEA function. The ability
to record H2O2 longer than it is possible to detect Glu suggests that the enzyme
layer may either be degrading or the enzyme may be dysfunctional (Valdes and
Moussy, 2000) or detaching from the surface of the MEA. However, this must be
further analyzed to determine the exact cause of the loss of enzyme function.
Current microdialysis studies report significant damage to brain tissue
within 45 hours upto 1.4 mm of the area surrounding the probe implant site
including altered mitochondria and endoplasmic reticulum.

This supports an

intracellular chemical disruption in the neuronal processes, in addition to an
observed neuronal density loss up to 400 µm away from the microdialysis implant
site (Clapp-Lilly et al., 1999).

Additionally, Borland et al. (2005) observed

disrupted dopamine release and uptake at least 220 µm remote from the
microdialysis probe approximately 2 hours following probe placement. However,
histological studies performed to examine the effects of chronic implantation of
our MEA showed minimal damage (50-100 µm) on surrounding brain tissue up to
8 weeks post implant as measured by an astrocyte marker and one week as
measured by a microglia marker with a return to control levels by 24-week postimplantation.

The damage observed with chronic microdialysis implantations

may account for the discrepancies between studies in terms of the source of the
Glu measured.
Copyright © Erin Cathleen Rutherford
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Figure 5.1: Cresyl Violet Staining of Microelectrode Arrays Chronically Implanted in the
Right Prefrontal Cortex of a Long Evans Rat
Cresyl violet staining of neuropil. MEA tract is clearly visible in the right PFC.
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Figure 5.2: GFAP Staining of the Right Prefrontal Cortex of Long Evans Rats with Chronic
Microelectrode Array Implantations
Rats were sacrificed after 1 or 3 days, 1, 2, 4, 8, 16, or 24 weeks with the implanted MEA.
Significance was vs. 1 day implantations (n=4; *p<0.05; **p<0.01). Inset shows Glu clearance
(t80) on days 3 and 7 post-implantation in the PFC of Long Evans rats. Trend of faster Glu
clearance correlates with trend of increased astrocyte density on days 3 and 7 post-implantation
(n=7).
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Figure 5.3: GFAP Staining of Right Prefrontal Cortex of a Long Evans Rat after an 8 Week
Implant
Image of the right PFC of a Long Evans rat after an 8 week implantation stained with GFAP.
MEA tract is clearly visible. Adapted from Rutherford et al., 2007.
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Figure 5.4: Image of GFAP and Iba1 Staining in the Prefrontal Cortex of Long Evans Rats
after 3 Day, 1 Week, 4 Week, and 24 Week Implantations
Image of the control hemisphere (upper left) and implant site in the PFC of Long Evans rats after
3 days, 1 week, 4 weeks or 24 weeks implant stained with GFAP (red) and Iba1 (green). A glial
scar can be seen along the MEA tract at 24 weeks.
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Figure 5.5: Iba1 staining of the Right Prefrontal Cortex of Long Evans Rats with Chronic
Microelectrode Array Implantations
Rats implanted with pedestal MEAs were sacrificed after 1 or 3 days, 1, 2, 4, 8, 16, or 24 weeks.
The contralateral hemisphere was used as controls (n=4; ***p<0.001 vs. 1 day; ^^^p<0.001 vs. 1
week control).
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Figure 5.6 :Iba1 Staining of the Right Prefrontal Cortex of a Long Evans Rat after an 8
Week Implant
Image of the right PFC of a Long Evans rat after an 8 week implantation stained with Iba1 (left).
MEA tract is clearly visible. Image of the contralateral hemisphere in a Long Evans rat after 8
week implantation stained with Iba1 (right). Increased GFAP staining is due to a stainless steel
skull screw coming into contact with the brain and is indicative of an injury. Adapted from
Rutherford et al., 2007.
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Chapter Six: Does Tail-Pinch Stress Affect L-Glutamate Levels in the Striatum
and Prefrontal Cortex of Male Fischer 344 and Long Evans Rats?
Introduction
Stress can play a major role in the development, progression and
exacerbation of symptoms associated with many disorders, including addiction,
schizophrenia, and Parkinson’s disease.

It has been suggested that Glu

neurotransmission activation in the PFC is a common mechanism that may allow
stress to influence both normal and abnormal processes that maintain cognition
and affect (Moghaddam, 2002).

The rodent medial PFC (infralimbic and

prelimbic areas) is suggested to be the brain area responsible for executing
function, such as working memory (Aultman and Moghaddam, 2001; Delatour
and Gisquet-Verrier, 1996; Floresco et al., 1996; Granon and Poucet, 1995;
Kesner et al., 1996; and Seamans et al., 1995) and other cognitive functions. All
PFC efferents and the majority of the afferents to the PFC, such as projections
from

the

thalamus,

hippocampus,

and

amygdala,

are

glutamatergic.

Glutamatergic neurotransmission in the PFC modulates or mediates many
aspects of stress response, such as activation of the hypothalamic-pituitaryadrenal (HPA) axis and monoamine neurotransmission. Glu is also abundant in
the striatum which is involved in the limbic system and motor functions and as
such, is connected to the PFC through various pathways. Although the striatum
is not commonly studied in conjunction with stress, the connection between the
PFC and striatum present the striatum as another potential area to be influenced
by stress.
Previous studies (Gilad et al., 1990; Moghaddam, 1993; Jedema and
Moghaddam, 1994; Bagley and Moghaddam, 1997; Takahata and Moghaddam,
1998; Bland et al. 1999) have reported on stress response and Glu involvement
in awake animals.

Microdialysis studies evaluating handling and swimming

stress showed elevated Glu stress response in the PFC compared to the striatum
(Gilad et al., 1990; Moghaddam, 1998). Additionally, Glu response to stress was
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shown to decrease with successive tail-pinch applications administered over a
single day (Bagley and Moghaddam, 1997; Moghaddam, 2002). However, these
studies did not have the temporal and spatial resolution that is possible with our
chronic pedestal microelectrode implants.
In the present study we investigated the dynamics of Glu in response to
tail-pinch stress in the PFC and striatum of Fischer 344 and Long Evans rats
using our chronically implanted pedestal MEA.

We examined the duration,

maximum amplitude, and fast dynamics of the Glu signal change due to a
physiological event (tail-pinch stressor). In addition, we were able to compare
the changes in Glu response to stress in the striatum and PFC over multiple
days.
Methods
Animals were housed in the conditions described in Chapter Two. Male
Fischer 344 and Long Evans rats were between three and six months at the time
of implantation surgery. Surgical procedures, MEA implantation in the striatum
and PFC, and recording procedures followed those outlined in Chapter Two.
Briefly, male Fischer 344 and Long Evans rats were implanted either in the
striatum or PFC under isoflurane anesthesia and allowed to recover for two days
prior to recording sessions. On recording days 4 and 6 post-implantation, rats
were allowed approximately ten minutes to acclimate to the recording chamber
prior to establishing a connection between the implanted MEA and the FAST-16
recording system. Once a connection was established and recordings started, a
sampling rate of 1 Hz was maintained throughout the recording session. After
recording for approximately 30 minutes, or longer if needed, and baseline was
established, a five minute tail pinch stressor was performed by applying a
clothespin approximately one inch from the base (where the tail meets the body)
of the tail.

Data analysis involved an ANOVA with a Tukey’s post hoc test.

Significance was determined at p<0.05.
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Results
Five minute tail-pinch stressors were performed while recording Glu
signals on a second-by-second basis in Fischer 344 and Long Evans rats
chronically implanted either in the striatum or PFC (Figures 6.1, 6.2, 6.3, and
6.4). We were able to measure changes in Glu due to physiological stimuli in the
awake behaving rat.

Several parameters surrounding the tail-pinch were

examined, including the duration of the tail-pinch response, the maximum
amplitude of the tail-pinch, the area under the curve for the tail-pinch response,
the number of peaks through out the tail-pinch response defined as a change of
at least 15% over resting Glu levels, and the total peak area for the tail-pinch
response.
The duration of the tail-pinch response was defined as the time from the
beginning of the tail-pinch until the Glu levels returned to baseline. The duration
of tail-pinch responses did not vary between brain regions within a single rat
strain (either the Long Evans or Fischer 344 rats). However, both the striatum
(26.5 ± 9.8 µM) and PFC (27.5 ± 6.2 µM) in the Fischer 344 rats were
significantly elevated (p< 0.05) compared to their counterparts in the Long Evans
rats (striatum: 11.5 ± 2.4 µM; PFC: 13.6 ± 2.9 µM) (Figure 6.5).
The maximum amplitude of the tail-pinch response was also examined.
There were no significant differences observed between brain regions or rat
strains. This could be due to the large variation observed with the PFC (8.9 ± 4.3
µM) and striatum (1.1 ± 0.4 µM) of the Long Evans rats and the striatum (7.9 ±
6.4 µM) and PFC (4.9 ± 2.0 µM) of the Fischer 344 rats (Figure 6.6). Similarly,
when examining the area under the curve for the Glu tail-pinch response a large
variance was observed in the PFC (8025 ± 4273 arbitrary units) and striatum
(1061 ± 730.4 arbitrary units) of the Long Evans rats and the striatum (4648 ±
4021 arbitrary units) and PFC (6795 ± 5209 arbitrary units) of the Fischer 344
rats (Figure 6.7).
To get a better understanding of the shape of the tail-pinch response, the
number of peaks was analyzed. There was no significance difference observed
between rat strains or brain regions. However, there was a trend of elevated
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number of peaks during the tail-pinch response observed in the PFC of the Long
Evans (31.0 ± 9.4 peaks) and Fischer 344 (12.7 ± 5.5 peaks) rats compared to
the striatum of their respective counterparts (Long Evans: 17.6 ± 2.8 peaks;
Fischer 344: 9.5 ± 1.5 peaks) (Figure 6.8). Additionally, the total peak area for
the tail-pinch response was analyzed.

The striatum (725.5 ± 497.2 arbitrary

units) and PFC (4581 ± 2322 arbitrary units) in the Long Evans rats and the
striatum (4497 ± 4117 arbitrary units) and PFC (6690 ± 5148 arbitrary units) in
the Fischer 344 rats had a large degree of variance (Figure 6.9).
Discussion
Our laboratory was interested in stress and how it affects Glu levels in the
striatum and PFC of Fischer 344 and Long Evans rats. We wanted to determine
if we could measure changes in extracellular Glu levels in a behaviorally relevant
situation.

To examine this, we performed a five minute tail-pinch stress on

Fischer 344 and Long Evans rats with chronic MEA implants in the striatum or
PFC. We observed large variations in tail-pinch response, even in an inbred rat
strain (Fischer 344). We also observed fast, robust Glu responses that would not
be able to be seen when using conventional microdialysis.
When analyzing the duration of the tail-pinch response, which we define
as the beginning of the tail pinch and lasts until Glu levels return to resting levels,
no significant difference was observed between the PFC and striatum within
either the Long Evans or Fischer 344 rats. However, there was a significant
difference observed between the Fischer 344 and Long Evans rats in the PFC
(27.5 ± 6.2 minutes and 13.6 ± 2.9 minutes, respectively; p<0.05), and in the
striatum of Fischer 344 and Long Evans rats (26.5 ± 9.8 minutes and 11.5 ± 2.4
minutes, respectively; p<0.05) with the response in the Fischer 344 rats lasting
approximately two times those observed in the Long Evans rats. The tail-pinch
response in the Long Evans rats lasted approximately 10-15 minutes, regardless
of brain area, whereas the duration of the tail-pinch stress response in the
Fischer 344 rats was approximately 20-30 minutes (Figure 6.5), suggesting that
Fischer 344 rats remained stressed longer.
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The maximum amplitude was also examined and was defined as the
maximum peak height in Glu response during the duration of the tail-pinch
response. There was no significant difference between the rat strains (Long
Evans and Fischer 344) or between the brain regions (PFC and striatum) within
the rat strains (Figure 6.6). In an effort to examine possible differences between
rat strains and brain regions in response to tail-pinch stress more accurately, we
analyzed the data using area under the curve. This method accounted for the
duration of the Glu response to stress as well as the fluxuation of Glu response
amplitudes throughout the duration of the Glu tail-pinch response. There was no
significant difference in the area under the curve for tail-pinch stress between rat
strains or brain regions.

The averages for the area under the curve were

decreased in the striatum of both rat strains compared to the PFC in the
respective strains; however, the variance was too great to establish significance.
The lack of significance suggests that there may be a regulatory mechanism in
place in both the PFC and the striatum in the Fischer 344 and Long Evans rats
that acts to limit the Glu response to stress such that over a period of time, there
is a maximum total Glu concentration that can be achieved when the system is
functioning properly.
However, when analyzing the PFC and striatum, there was significance
observed in the duration of the Glu response to tail-pinch stress in Fischer 344
rats as compared to Long Evans rats, but no significance in either the maximum
amplitude or the area under the curve.

The current data suggest that the

striatum and PFC in the Long Evans rats must either have an increased number
of spikes in Glu concentration or an elevated Glu undertone in response to tailpinch stress compared to the Long Evans rats. To examine this possibility, the
number of peaks during the tail-pinch response was analyzed (Figure 6.8).
There was no significance observed in the number of peaks between brain
regions or rat strains. However, there was a trend with the number of peaks in
the PFC of both rat strains having an increased average number of peaks as
compared to the striatum in the respective rat strains (Figure 6.8). Additionally,
there was no significant difference in the total peak area between the rat strains
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or brain regions. Taken together, these data suggest that within a given rat strain
and brain region there may be difference in the general rise and fall, or tone, of
Glu.
The durations of the responses to tail-pinch were well within the sampling
range that can be observed using microdialysis.

Additionally, the maximum

amplitudes observed using our recording technology would be detected using
microdialysis.

However, current microdialysis studies lack the response time

necessary to see the fast changes in peak amplitudes that we were able to be
distinguished using our second-by-second recording capabilities.

Taken

together, these studies support that the improved temporal resolution of enzymebased MEAs can be used for reliable second-by-second measures of Glu in the
CNS of freely moving rats and recordings in awake animals are necessary to
accurately determine the fast dynamics of glutamatergic function.
Copyright © Erin Cathleen Rutherford
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Figure 6.1: Representative Tracing of a Five Minute Tail-Pinch Response in the Striatum of
a Long Evans Rat
Long Evans rats implanted in the striatum underwent a five minute tail-pinch stressor. Tail-pinch
is indicated by the solid black line.
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Figure 6.2: Representative Tracing of a Five Minute Tail-Pinch Response in the Prefrontal
Cortex of Long Evans Rats
Long Evans rats implanted in the PFC underwent a five minute tail-pinch stressor. Tail-pinch is
indicated by the solid black line.
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Figure 6.3: Representative Tracing of a Five Minute Tail-Pinch Response in the Striatum of
Fischer 344 Rats
Fischer 344 rats implanted in the striatum underwent a five minute tail-pinch stressor. Tail-pinch
is indicated by the solid black line.
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Figure 6.4: Representative Tracing of a Five Minute Tail-Pinch Response in the Prefrontal
Cortex of Fischer 344 Rats
Fischer 344 rats implanted in the PFC underwent a five minute tail-pinch stressor. Tail-pinch is
indicated by the solid black line.
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Figure 6.5: Duration of Response to a Five Minute Tail-Pinch in the Striatum and Prefrontal
Cortex of Fischer 344 and Long Evans Rats
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and
underwent a five minute tail-pinch stressor. The duration of the Glu response to the tail-pinch
was examined. Fischer 344 striatal responses were significantly increased compared to the
striatum of Long Evans rats (*p<0.05). Fischer 344 PFC responses were significantly increased
compared to the striatum of Long Evans rats (#p<0.05) (n=7, except Str F344 n=4).
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Figure 6.6: Maximum Amplitude during Tail-Pinch Response in the Striatum and Prefrontal
Cortex of Fischer 344 and Long Evans Rats
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and
underwent a five minute tail-pinch stressor. The maximum amplitude of the Glu response to the
tail-pinch was examined. No significant difference was observed (n=7, except Str F344 n=4).
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Figure 6.7: Area Under the Curve for Tail-Pinch Response in the Striatum and Prefrontal
Cortex of Fischer 344 and Long Evans Rats
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and
underwent a five minute tail-pinch stressor. The area under the curve of the Glu response to the
tail-pinch was examined. No significant difference was observed (n=7, except Str F344 n=4).
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Figure 6.8: Number of Peaks during Tail-Pinch Response in the Striatum and Prefrontal
Cortex of Fischer 344 and Long Evans Rats
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and
underwent a five minute tail-pinch stressor. The number of peaks during the Glu response to the
tail-pinch was examined. No significant difference was observed (n=7, except Str F344 n=4).
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Figure 6.9: Total Peak Area for Tail-Pinch Response in the Striatum and Prefrontal Cortex
of Fischer 344 and Long Evans Rats
Fischer 344 (F344) and Long Evans (LE) rats were implanted in the striatum (Str) or PFC and
underwent a five minute tail-pinch stressor. The area under the curve for the peaks during the
Glu response to the tail-pinch was examined. No significant difference was observed (n=7,
except Str F344 n=4).
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Chapter Seven: Preliminary Studies and Future Directions
Much work has been accomplished to develop and characterize the
enzyme-based ceramic MEA for use in freely behaving animal recordings. Over
the past several years there have been many advances in the freely moving
recording system that have allowed us to optimize Glu studies in the awake rat.
Our MEA design combined with our FAST-16 recording system has allowed for
second-by-second measures of Glu.

A new paddle design allowed for Glu

recordings on four independent Pt recording sites and that number will soon
increase to eight.

Employing the self-referencing technique has allowed for

measures of resting Glu levels and another way to verify that the analyte being
measured is Glu. Our laboratory has been successful in moving freely behaving
Glu recordings into a mouse model, which with the use of transgenic mouse
models will give us the opportunity to greatly enhance our knowledge of how the
glutamatergic system works and the possibility to study disease models more in
depth (Hascup et al., 2006). Due to the nature of our enzyme-based MEAs, we
are also capable of selectively measuring other analytes, such as dopamine and
acetylcholine.

This chapter is a compilation of the various trials, preliminary

studies, and future directions surrounding my work in the awake, freely behaving
rat.
In our initial studies (prior to the self-referencing capability) we wanted to
determine if we could measure changes in Glu levels in a behaviorally relevant
situation. Our laboratory was interested in stress and how it affects Glu levels in
the striatum. Glu tracings of a typical tail-pinch stress in the striatum of Fischer
344 rats can be seen in Figure 7.1. The Glu response due to a 5 minute tailpinch yielded a bimodal response. The initial phase was a rapid spike (A) lasting
approximately 20 seconds. The second phase (B) of the response had a plateau
appearance with a sustained increase in Glu levels compared to baseline (n=3).
These fast changes in Glu levels that occurred in the freely behaving rats due to
stress would not be accurately detectable using other current in vivo techniques,
such as microdialysis, for measuring Glu.

The prolonged plateau properties

observed in the Glu signals due to stress is most likely the response observed in
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current freely-moving microdialysis studies (Bagley and Moghaddam, 1997).
Subsequent tail-pinches in the striatum of Fischer 344 rats resulted in a
significantly decreased Glu response in both the spike (day 4 = 86.4 ± 7.5 µM vs.
day 6 = 3.8 ± 1.9 µM) (Figure 7.2) and plateau portions (day 4 = 5.6 ± 0.1 µM vs.
day 6 = 2.8 ± 0.1 µM; p<0.001) (Figure 7.3). These studies in the striatum of the
Fischer 344 rats were performed prior to having the capability to use the selfreferencing technique. Therefore, the above results reported for the Fischer 344
rat striatum tail-pinch stress data were reported as total Glu concentration and
were not subtracted from sentinel sites. The oscilloscope was used in all studies
and only signals matched with valid oscilloscope data were used.

Taken

together, these preliminary studies support that the improved temporal resolution
of enzyme-based MEAs can be used for reliable second-by-second measures of
Glu in the CNS of conscious freely moving rats and recordings in unanesthetized
animals are necessary to accurately determine the dynamics of glutamatergic
function.
We also have preliminary data in the freely moving rat that shows locally
applied DA results in robust, reproducible peaks (Figure 7.4). Since DA was
readily oxidized on our Pt recording surfaces, an enzyme coating was not
necessary. Instead, the MEAs were coated with the exclusion layer, Nafion®, as
with our Glu configured MEAs, to block interferents including DOPAC and
ascorbate based on charge, but still allowed for DA to reach the recording sites.
Next, two of the Pt recording sites (either 1 and 3 or 2 and 4) were electroplated
with another exclusion layer, meta phenylenediamine (mPD). mPD formed a
size exclusion layer that allowed molecules smaller than the matrix formed by
mPD, such as H2O2, to pass through. However, larger molecules, such as DA,
were not able to pass through the mPD layer. This coating procedure allowed
oxidation of DA on the Pt recording sites that were only coated with Nafion®, but
not on those coated with Nafion® and mPD.

Since mPD can be selectively

electropolymerized onto a Pt recording site, we can utilize side-by-side selfreferencing for the DA selective MEA. We were able to record resting DA levels,
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DA signals due to locally applied exogenous DA, and evoked DA release due to
a physiological event, a tail-pinch stress (Figure 7.5).
The acetylcholine MEA relied on the same enzymatic principle established
with the Glu configured MEA.

However, the acetylcholine MEA required 2

enzymes, choline oxidase and acetylcholinesterase.

Neither choline nor

acetylcholine is readily oxidized at +0.7 V and therefore, they require enzymatic
breakdown to H2O2 to be measured by our FAST-16 recording system.
Acetylcholinesterase breaks down acetylcholine into acetic acid and choline.
Choline is then broken down by choline oxidase into betaine and H2O2, which
can be oxidized at +0.7 V.

Again, by using the self-referencing techniques

previously described for Glu selective MEAs, we were able to measure signals
primarily due to acetylcholine. When the self-referencing technique is applied to
acetylcholine selective MEAs, the acetylcholinesterase and choline oxidase
coated sites were the analyte measuring sites and the sites coated with choline
oxidase, but not acetylcholinesterase, were the self-referencing sites. Using this
approach in the freely behaving rat, we were able to measure changes in
acetylcholine due to tail-pinch stress (Figure 7.6).
In addition to the tail-pinch stressor, our laboratory also wanted to
examine the affects of another possible stressor, such as exposure to a natural
predator, the fox. To accomplish this, Glu was continuously recorded in the
striatum of a Fischer 344 rat as previously described.

Once baseline was

established, fox urine was applied to a cotton ball and placed in the recording
chamber for 50 seconds. We observed a delayed slight increase in Glu levels
that immediately returned to baseline with the removal of the odor (Figure 7.7).
The delay could be accounted for by the time it would take for the smell to reach
all areas of the recording chamber.
We also examined another brain area, the somatosensory cortex, for Glu
response to a subcutaneous injection of a NMDA receptor antagonist (MK-801)
and contralateral vibrissae stimulation. There was no change in Glu levels in the
somatosensory cortex associated with the injection of MK-801 (1 mg/kg).
However, approximately 3.5 minutes after the MK-801 injection, the rat began to
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seize (Figure 7.8). There was an increase in Glu in the somatosensory cortex
that correlated in time with the seizure.

When examining the affects of

contralateral vibrissae stimulation on Glu in the somatosensory cortex a cotton
tipped applicator was used to brush against the vibrissae for either 30 seconds or
60 seconds. Vibrissae stimulation resulted in an increase in Glu activity in the
contralateral somatosensory cortex, but not an overall increase in Glu levels
(Figure 7.9).
Our laboratory also wanted to study the effects of circadian rhythm on
glutamatergic function on a second-by-second basis. This would give us the
ability to monitor rapid changes that may occur during light and dark cycles in
addition to the overall glutamatergic tone associated with these cycles.
Additionally, with the capacity to measure in the awake behaving rat on a
second-by-second time scale, we could couple our technology with an activity
monitor to determine a direct association between activity level of the rat and
changes in Glu levels. An important first step was taken to pursue this merging
of technologies. We were able to continuously measure Glu in the PFC of a
Long Evans rat for over 15 hours. We observed an overall increase in resting
extracellular Glu levels in the PFC of a Long Evans rat that was associated with
the dark cycle, the time when rats are more active (Figure 7.10).
Another area of interest is to combine the implantation of our MEAs with
imaging techniques, such as magnetic resonance imaging (MRI). This capability
could open the door to many research avenues. In addition to being able to
determine tissue damage associated with chronic implant of our MEA, the ability
to perform MRI guided implantation and recordings would allow us to strategically
and accurately place the MEA in the brain area of interest and could allow us to
record from small or hard to locate brain areas that would not be possible without
guided placement. A specific type of MRI, functional MRI (fMRI), in conjunction
with MEA recordings would allow us to correlate changes in neurotransmitter
levels with functional activation of specific brain areas. We have taken a positive
first step in being able to combine these two scientific methods. We have brain
images from a rat that underwent chronic implantation of our MEA.
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The

implantation procedure followed those outlined in Chapter Two, except skull
screws and guide cannula were not used since their metallic properties would
interfere with the MRI scan.

After one day post-implantation, the rat was

anesthetized with urethane to minimize their movement in the MRI scanner and
was sacrificed following imaging.

Preliminary T1 MRI data showing images

taken of the chronic MEA implantation clearly showed the tract from the
implantation (Figure 7.11).

Additionally, the MRI scan revealed that there is

little to no edema associated with chronic implantation of our MEA.

This

supports our histopathological data of the chronic MEA implantations (see
Chapter Five) which showed that our implantation materials and methods
resulted in very little damage to the surrounding brain tissue as measured by
GFAP (an astrocytic marker) and Iba1 (a microglial marker) that extended only
approximately 50 – 100 µm into the tissue immediately surrounding the
implantation site.
Many of these preliminary trials and studies have laid the groundwork for
future experiments. We have been able to verify that by using our chronically
implanted enzyme-based MEAs we are able to independently measure multiple
analytes with our self-referencing technique. However, an important advantage
of microdialysis is the ability to measure multiple analytes simultaneously. Our
laboratory is in the process of developing MEAs with up to 36 recording sites.
The additional recording sites will allow for multiple analytes to be measured
using the self-referencing technique on a single MEA in a given brain area.
These advances bring the promise of studies to evaluate neurotransmitter
interactions in response to behavioral and chemical stimuli, such as the
dopamine-Glu interactions that may exist in several brain areas, including the
PFC and striatum.
Copyright © Erin Cathleen Rutherford
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Figure 7.1: Tail-Pinch Response in the Fischer 344 Rat Striatum
Representative trace from the striatum of a Fischer 344 rats of a Glu response to a five minute
tail-pinch. The response was bi-phasic with an initial rapid spike in Glu followed by prolonged
plateau-like Glu levels. The duration of the tail-pinch is indicated by the solid black line.
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Figure 7.2: Fischer 344 Tail-Pinch Striatal Spike Response
Pedestal MEAs were implanted in the striatum of Fischer 344 rats. Rats underwent a five minute
tail-pinch stressor. The maximum amplitude of the Glu response during the initial spike phase to
the tail-pinch was examined. The maximum amplitude of the spike response was significantly
decrease during the second tail-pinch (TP2), which occurred on day 6 post-implantation, as
compared to the first tail-pinch (TP1), which occurred on day 4 post-implantation (***p<0.001).
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Figure 7.3: Fischer 344 Tail-Pinch Striatal Plateau Response
Pedestal MEAs were implanted in the striatum of Fischer 344 rats. Rats underwent a five minute
tail-pinch stressor. The maximum amplitude of the Glu response during the plateau phase to the
tail-pinch was examined. The maximum amplitude of the plateau response was significantly
decrease during the second tail-pinch (TP2), which occurred on day 6 post-implantation, as
compared to the first tail-pinch (TP1), which occurred on day 4 post-implantation (***p<0.001).
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Figure 7.4: Local Application of Dopamine (200 µM, 1 µL) in the Striatum of a Long Evans
Rat
Single recording of locally applied DA (200 µM, 1 µL) in the striatum of Long Evans rats. DA was
locally applied (indicated by arrows) and detected using a self-referencing MEA. Tracing shown
is the result of subtracting the self-referencing site (Nafion® and mPD) from the Nafion® coated
site. DA peaks were robust and reproducible.
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Figure 7.5: Dopamine Tail-Pinch Response in the Striatum of a Long Evans Rat
Single DA recording of a five minute tail-pinch response from the striatum of a Long Evans rat.
The duration of the tail-pinch is indicated by the solid black line.
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Figure 7.6: Achetylcholine Tail-Pinch Response in the Prefrontal Cortex of a Long Evans
Rat
Single acetylcholine recording of a five minute tail-pinch response from the PFC of a Long Evans
rat. The duration of the tail-pinch is indicated by the solid black line.
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Figure 7.7: Glutamatergic Response to Fox Urine Exposure in the Striatum of a Fischer 344
Rat
Single glutamatergic recording of a response to fox urine odor in the striatum of a Fischer 344 rat.
The duration of the fox urine exposure is indicated by the solid black line.
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Figure 7.8: Glutamatergic Response to a NMDA Receptor Antagonist (MK-801) in the
Somatosensory Cortex of a Long Evans Rat
Single glutamatergic recording of a response to a subcutaneous injection of MK-801 (1 mg/kg) in
the somatosensory cortex of a Long Evans rat. Arrow indicates induction of a seizure
approximately 3.5 minutes following injection.
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Figure 7.9: Glutamatergic Response to Contralateral Vibrissae Stimulation in the
Somatosensory Cortex of a Long Evans Rat
Single glutamatergic recording of a 30 second (left) and 60 second (right) contralateral vibrissae
stimulation response from the somatosensory cortex of a Long Evans rat. The duration of the
vibrissae stimulation is indicated by the solid black line.
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Figure 7.10: Continuous Second-By-Second Recording of L-Glutamate over Light and Dark
Cycles
Single continuous recording of resting Glu levels in the PFC of a Long Evans rat encompassing
the light (non-shaded region) and dark cycle (shaded region). Glu levels were elevated during
the dark cycle as compared to the light cycle.
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A

B

C

Figure 7.11: T1 MRI of an Implanted MEA in the Prefrontal Cortex of a Long Evans Rat
A) Coronal view of a T1 MRI of a MEA implanted in the right PFC of a Long Evans rat. B)
Horizontal view of a T1 MRI of a MEA implanted in the right PFC of a Long Evans rat. C) Sagital
view of a T1 MRI of a MEA implanted in the right PFC of a Long Evans rat. Arrows indicate MEA
implant site.
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